<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-04-29T00:38:00Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:9985577" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:9985577</identifier>
        <datestamp>2023-03-06</datestamp>
        <setSpec>springeropen</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article" dtd-version="1.3">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Clin Oral Investig</journal-id>
              <journal-id journal-id-type="iso-abbrev">Clin Oral Investig</journal-id>
              <journal-title-group>
                <journal-title>Clinical Oral Investigations</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">1432-6981</issn>
              <issn pub-type="epub">1436-3771</issn>
              <publisher>
                <publisher-name>Springer Berlin Heidelberg</publisher-name>
                <publisher-loc>Berlin/Heidelberg</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC9985577</article-id>
              <article-id pub-id-type="pmcid">PMC9985577</article-id>
              <article-id pub-id-type="pmc-uid">9985577</article-id>
              <article-id pub-id-type="pmid">36707442</article-id>
              <article-id pub-id-type="pmid">36707442</article-id>
              <article-id pub-id-type="publisher-id">4868</article-id>
              <article-id pub-id-type="doi">10.1007/s00784-023-04868-9</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Original Article</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Randomized clinical study of injectable dextrin-based hydrogel as a carrier of a synthetic bone substitute</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Machado</surname>
                    <given-names>Alexandra</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Pereira</surname>
                    <given-names>Isabel</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Costa</surname>
                    <given-names>Filomena</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Brandão</surname>
                    <given-names>Ana</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff3">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Pereira</surname>
                    <given-names>José Eduardo</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff4">4</xref>
                  <xref ref-type="aff" rid="Aff5">5</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Maurício</surname>
                    <given-names>Ana Colette</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff6">6</xref>
                  <xref ref-type="aff" rid="Aff7">7</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Santos</surname>
                    <given-names>José Domingos</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff8">8</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Amaro</surname>
                    <given-names>Inês</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff9">9</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Falacho</surname>
                    <given-names>Rui</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff10">10</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Coelho</surname>
                    <given-names>Rui</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff11">11</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Cruz</surname>
                    <given-names>Nuno</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff12">12</xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                  <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5655-0015</contrib-id>
                  <name>
                    <surname>Gama</surname>
                    <given-names>Miguel</given-names>
                  </name>
                  <address>
                    <email>fmgama@deb.uminho.pt</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                </contrib>
                <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.10328.38</institution-id><institution-id institution-id-type="ISNI">0000 0001 2159 175X</institution-id><institution>CEB, Centre of Biological Engineering, </institution><institution>University of Minho, </institution></institution-wrap>Campus de Gualtar, 4710-057 Braga, Portugal </aff>
                <aff id="Aff2"><label>2</label>LABBELS, Associate Laboratory, Braga, Guimarães Portugal </aff>
                <aff id="Aff3"><label>3</label>Biosckin, Molecular and Cell Therapies S.A., TecMaia, Rua Engenheiro Frederico Ulrich 2650, 4470-605 Maia, Portugal </aff>
                <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.12341.35</institution-id><institution-id institution-id-type="ISNI">0000000121821287</institution-id><institution>CECAV, Animal and Veterinary Research Centre, </institution><institution>University of Trás-os-Montes and Alto Douro, </institution></institution-wrap>5001-801 Vila Real, Portugal </aff>
                <aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.12341.35</institution-id><institution-id institution-id-type="ISNI">0000000121821287</institution-id><institution>Department of Veterinary Sciences, </institution><institution>University of Trás-os-Montes and Alto Douro, </institution></institution-wrap>5001-801 Vila Real, Portugal </aff>
                <aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.5808.5</institution-id><institution-id institution-id-type="ISNI">0000 0001 1503 7226</institution-id><institution>Departamento de Clínicas Veterinárias, Instituto de Ciências Biomédicas de Abel Salazar (ICBAS), </institution><institution>Universidade do Porto (UP), </institution></institution-wrap>Rua de Jorge Viterbo Ferreira, N° 228, 4050-313 Porto, Portugal </aff>
                <aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="GRID">grid.5808.5</institution-id><institution-id institution-id-type="ISNI">0000 0001 1503 7226</institution-id><institution>Centro de Estudos de Ciência Animal (CECA), Instituto de Ciências, </institution><institution>Tecnologias e Agroambiente da Universidade do Porto (ICETA), </institution></institution-wrap>Rua D. Manuel II, Apartado 55142, 4051-401 Porto, Portugal </aff>
                <aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="GRID">grid.5808.5</institution-id><institution-id institution-id-type="ISNI">0000 0001 1503 7226</institution-id><institution>REQUIMTE/LAQV, Departamento de Engenharia Metalúrgica e Materiais, Faculdade de Engenharia, </institution><institution>Universidade do Porto, </institution></institution-wrap>Rua Dr. Roberto Frias, 4200-495 Porto, Portugal </aff>
                <aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="GRID">grid.8051.c</institution-id><institution-id institution-id-type="ISNI">0000 0000 9511 4342</institution-id><institution>Institute of Integrated Clinical Practice, Faculty of Medicine, </institution><institution>University of Coimbra, </institution></institution-wrap>3004-504 Coimbra, Portugal </aff>
                <aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="GRID">grid.8051.c</institution-id><institution-id institution-id-type="ISNI">0000 0000 9511 4342</institution-id><institution>Institute of Oral Implantology and Prosthodontics, Faculty of Medicine, </institution><institution>University of Coimbra, </institution></institution-wrap>3004-504 Coimbra, Portugal </aff>
                <aff id="Aff11"><label>11</label>RESDEVMED, Unipessoal Lda., Travessa do Navega, 436 C, 3885-183 Ovar, Portugal </aff>
                <aff id="Aff12"><label>12</label><institution-wrap><institution-id institution-id-type="GRID">grid.410675.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 2325 3084</institution-id><institution>Faculty of Dentistry, </institution><institution>Universitat Internacional de Catalunya, </institution></institution-wrap>08017 Barcelona, Spain </aff>
              </contrib-group>
              <pub-date pub-type="epub">
                <day>28</day>
                <month>1</month>
                <year>2023</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>28</day>
                <month>1</month>
                <year>2023</year>
              </pub-date>
              <pub-date pub-type="ppub">
                <year>2023</year>
              </pub-date>
              <volume>27</volume>
              <issue>3</issue>
              <fpage>979</fpage>
              <lpage>994</lpage>
              <history>
                <date date-type="received">
                  <day>2</day>
                  <month>3</month>
                  <year>2022</year>
                </date>
                <date date-type="accepted">
                  <day>14</day>
                  <month>1</month>
                  <year>2023</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© The Author(s) 2023</copyright-statement>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
                </license>
              </permissions>
              <abstract id="Abs1">
                <sec>
                  <title>Objectives</title>
                  <p id="Par1">This study aimed to improve the performance and mode of administration of a glass-reinforced hydroxyapatite synthetic bone substitute, Bonelike by Biosckin® (BL®), by association with a dextrin-based hydrogel, DEXGEL, to achieve an injectable and moldable device named DEXGEL Bone.</p>
                </sec>
                <sec>
                  <title>Methods</title>
                  <p id="Par2">Twelve participants requiring pre-molar tooth extraction and implant placement were enrolled in this study. BL® granules (250–500 µm) were administered to 6 randomized participants whereas the other 6 received DEXGEL Bone. After 6 months, a bone biopsy of the grafted area was collected for histological and histomorphometric evaluation, prior to implant placement. The performance of DEXGEL Bone and BL® treatments on alveolar preservation were further analyzed by computed tomography and Hounsfield density analysis. Primary implant stability was analyzed by implant stability coefficient technique.</p>
                </sec>
                <sec>
                  <title>Results</title>
                  <p id="Par3">The healing of defects was free of any local or systemic complications. Both treatments showed good osseointegration with no signs of adverse reaction. DEXGEL Bone exhibited increased granule resorption (<italic>p</italic> = 0.029) accompanied by a tendency for more new bone ingrowth (although not statistically significant) compared to the BL® group. The addition of DEXGEL to BL® granules did not compromise bone volume or density, being even beneficial for implant primary stability (<italic>p</italic> = 0.017).</p>
                </sec>
                <sec>
                  <title>Conclusions</title>
                  <p id="Par4">The hydrogel-reinforced biomaterial exhibited an easier handling, a better defect filling, and benefits in implant stability.</p>
                </sec>
                <sec>
                  <title>Clinical relevance</title>
                  <p id="Par5">This study validates DEXGEL Bone safety and performance as an injectable carrier of granular bone substitutes for alveolar ridge preservation.</p>
                </sec>
                <sec>
                  <title>Trial registration</title>
                  <p id="Par6">European Databank on Medical Devices (EUDAMED) No. CIV-PT-18–01-02,705; Registo Nacional de Estudos Clínicos, RNEC, No. 30122.</p>
                </sec>
                <sec>
                  <title>Supplementary Information</title>
                  <p>The online version contains supplementary material available at 10.1007/s00784-023-04868-9.</p>
                </sec>
              </abstract>
              <kwd-group xml:lang="en">
                <title>Keywords</title>
                <kwd>Synthetic bone</kwd>
                <kwd>Dextrin</kwd>
                <kwd>Injectable hydrogel</kwd>
                <kwd>Alveolar preservation</kwd>
              </kwd-group>
              <funding-group>
                <award-group>
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001871</institution-id>
                      <institution>Fundação para a Ciência e a Tecnologia</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>SFRH/BD/132000/2017</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Machado</surname>
                      <given-names>Alexandra</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
              </funding-group>
              <funding-group>
                <award-group>
                  <funding-source>
                    <institution>Universidade do Minho</institution>
                  </funding-source>
                </award-group>
                <open-access>
                  <p>Open access funding provided by FCT|FCCN (b-on).</p>
                </open-access>
              </funding-group>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>issue-copyright-statement</meta-name>
                  <meta-value>© Springer-Verlag GmbH Germany, part of Springer Nature 2023</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <body>
            <sec id="Sec1">
              <title>Introduction
</title>
              <p id="Par7">Post-extraction bone remodeling is an inevitable natural phenomenon and can lead to significant ridge dimensional changes with loss of height and width of the alveolar bone [<xref ref-type="bibr" rid="CR1">1</xref>]. Placing space-maintaining grafts in the edentulous site at the time of extraction is a common approach to prevent or minimize impairment of the supporting structures of an implant [<xref ref-type="bibr" rid="CR2">2</xref>]. Bone regeneration procedures are essential to successfully settling an implant afterwards, restoring the site with satisfactory functionality and aesthetics. The design of shape fitting hydrogels (HGs) is a recent trend intended to circumvent the poor cohesivity and injectability that restrain bone substitutes use as bone fillers [<xref ref-type="bibr" rid="CR3">3</xref>–<xref ref-type="bibr" rid="CR5">5</xref>], conferring suitability for minimal invasive procedures.</p>
              <p id="Par8">DEXGEL is an in situ gelling hydrogel (WO/2011/070529A2) [<xref ref-type="bibr" rid="CR6">6</xref>] with oxidized dextrin as the base component. Dextrin is a low-cost, broadly available raw material derived from starch, widely used in many industrial applications and accepted as a generally-recognized-as-safe (GRAS) food ingredient [<xref ref-type="bibr" rid="CR7">7</xref>]. Dextrin is available in medical grade, has high solubility in water and DMSO, and holds hydroxyl groups suitable for bioconjugation, which has prompted this glucose polymer for several biomedical applications [<xref ref-type="bibr" rid="CR8">8</xref>], including as hydrogels [<xref ref-type="bibr" rid="CR9">9</xref>–<xref ref-type="bibr" rid="CR11">11</xref>]. In this work, dextrin was firstly oxidized (ODEX) with sodium periodate to bear aldehyde groups suitable to cross-link with adipic acid dihydrazide (ADH) amine groups, without any chemical initiator that could be potentially harmful for any agents to be embedded within it [<xref ref-type="bibr" rid="CR12">12</xref>]. ODEX and ADH are spontaneously stitched together upon contact by Schiff base reaction, creating hydrazone bonds (R<sub>2</sub> C = NNR<sub>2</sub>) [<xref ref-type="bibr" rid="CR13">13</xref>]. Hydrazone linkages are reversible in water [<xref ref-type="bibr" rid="CR14">14</xref>], gradually dismantling the hydrogel network as the free and bound polymer chains reach for constant equilibrium. These dynamic covalent bonds endow HGs with injectability and moldability, acquiring a versatile array of shapes for a better defect filling.</p>
              <p id="Par9">The polysaccharide nature of DEXGEL mimics the extracellular matrix of native bone, offering excellent biocompatibility. We have previously reported DEXGEL suitability as a carrier of nanogels, cells, biomolecules, and granular ceramics [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR15">15</xref>–<xref ref-type="bibr" rid="CR18">18</xref>]. Moreover, biocompatibility, safety, and effectiveness were assessed through a battery and a combination of in vitro and in vivo approaches. DEXGEL has demonstrated in vitro cyto- and genocompatibility [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR19">19</xref>]. In vivo biocompatibility and safety were demonstrated through the assessment of the inflammatory response in rat subcutaneous implants [<xref ref-type="bibr" rid="CR16">16</xref>], subacute systemic toxicity, and skin sensitization using rodent models [<xref ref-type="bibr" rid="CR18">18</xref>]. The effectiveness of the DEXGEL combined with BL® granules was demonstrated in two different bone defects: in goat critical-sized bone defects [<xref ref-type="bibr" rid="CR17">17</xref>] and tibial fractures [<xref ref-type="bibr" rid="CR18">18</xref>]. After extensive pre-clinic evaluation and formulation design, DEXGEL is ready for the first clinical assessment as an injectable and moldable carrier of BL® granules.</p>
              <p id="Par10">Bone graft synthetic substitutes are desired to overcome the limited source and significant morbidity associated with the harvesting of autologous bone grafts [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>]. BL®, property of Biosckin, Molecular and Cell Therapies, S.A. (WO2010021559A1) [<xref ref-type="bibr" rid="CR22">22</xref>], is a synthetic bone graft designed to mimic the inorganic composition of bone. It has been a subject of extensive characterization and clinical evaluation, which provided the conformity of the material for human use [<xref ref-type="bibr" rid="CR23">23</xref>–<xref ref-type="bibr" rid="CR30">30</xref>]. Particularly, BL® granules (250 to 500 μm) have been used successfully in maxillofacial surgery to repair bone defects caused by removal of cysts and elevation of the maxillary sinus, resulting in partial regeneration of the bone defect with no adverse reaction [<xref ref-type="bibr" rid="CR30">30</xref>], and recently functioned as a space filler in appendicular bone defects and maxillary/mandibular bone defects, promoting a faster bone fusion in 14 animals [<xref ref-type="bibr" rid="CR31">31</xref>]. Although currently unavailable, this study intends to accelerate BL® (250 to 500 μm) market re-entry, now as an innovative injectable device.</p>
              <p id="Par11">This clinical study aimed to improve the performance and mode of administration of the glass-reinforced hydroxyapatite (HA) synthetic bone substitute, BL®, by association with dextrin-based hydrogel, DEXGEL, in the management of alveolar bone. Biocompatibility and bone ingrowth are crucial parameters to be examined for clinical acceptability. Herein, we report a study that aims to validate the clinical safety and efficacy of DEXGEL Bone (DEXGEL + BL®) for the treatment of bone defects through the following analysis: (a) assess the capacity and performance of DEXGEL both as a bioceramic vehicle and an adjuvant matrix in the bone regeneration process, (b) assess the volume and quality of regenerated bone, (c) assess the primary stability of the dental implant, and (d) assess granule stabilization and ease of clinical use. DEXGEL Bone will be applied as an intermediate alveolar regeneration procedure from tooth extraction moment to implant placement, aiming at achieving a volume of bone formed after 6 months equal to the initial post-extraction alveolar volume — primary endpoint.</p>
            </sec>
            <sec id="Sec2">
              <title>Materials and methods</title>
              <sec id="Sec3">
                <title>Study design and overall clinical procedures</title>
                <p id="Par12">G*Power 3.1.9.2 software was used a priori to define sample size (Fig. <xref rid="MOESM1" ref-type="media">1</xref> SI). This pilot study was designed for a two-tailed analysis with Student’s <italic>t</italic>-test or Wilcoxon signed rank test (depending on the normality of the results), with a confidence interval (statistical power) of 95% (1 − <italic>β</italic> = 0.95), with a probability of occurrence of a type 1 error of 5% (<italic>α</italic> = 0.05) and assuming an <italic>effect size dz</italic> of 2. The analysis determined that a total of 6 participants for each group were needed to meet aforementioned parameters for the primary endpoint of this study: the volume of bone formed after 6 months equals to the initial post-extraction alveolar volume. All of the participants underwent tooth extraction and socket preservation, with test and control group materials (parallel group design), for 6 months before implant placement.</p>
                <p id="Par13">The overall clinical study involved seven visits to the study facilities by each patient, as listed in Table <xref rid="Tab1" ref-type="table">1</xref>. Postoperative clinical evaluations were performed after 3, 10, and 24 days to determine the presence of any complications such as infection, inflammation, wound dehiscence, or loss of graft material. After 6 months, clinical examinations were performed following implant placement. Afterwards, patients were still closely followed by the dentist over an extended period, however, with no relevance to this paper.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Overall study procedures listed by order of accomplishment</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Medical visit</th><th align="left">Main procedures</th></tr></thead><tbody><tr><td align="left">1st recruitment interview</td><td align="left">The candidate is invited to participate in the study; the anamnesis, inclusion, and exclusion criteria are reviewed; and if the candidate is eligible to participate, the information leaflet and declaration of consent are signed</td></tr><tr><td align="left">2nd pre-surgical visit</td><td align="left">Computed tomography (CT). This visit could be done on the same day as the candidate’s recruitment interview or the same day as the surgical visit</td></tr><tr><td align="left">3rd surgical intervention</td><td align="left">Surgery for tooth extraction, fill the alveolar socket with medical device and closure of the surgical wound</td></tr><tr><td align="left">4th first check-up visit</td><td align="left">3 days post-surgery: check-up for visual examination of the extraction site and tissue condition</td></tr><tr><td align="left">5th second check-up visit</td><td align="left">1 week after first check-up visit: check-up for visual examination of the extraction site and tissue condition, and for suture removal</td></tr><tr><td align="left">6th third check-up visit</td><td align="left">2 weeks after second check-up visit: check-up for visual examination of the extraction site and tissue condition</td></tr><tr><td align="left">7th pre-surgical visit</td><td align="left">6 months post-surgery: CT examination. This visit could be done few days before or on the same day as the surgical re-entry</td></tr><tr><td align="left">8th surgical re-entry</td><td align="left">6 months post-surgery: collect bone sample and evaluate tissue condition, following implant placement</td></tr></tbody></table></table-wrap></p>
              </sec>
              <sec id="Sec4">
                <title>Recruitment</title>
                <p id="Par14">The recruitment process began with the dissemination of the clinical study within Hospital da Luz, Coimbra. The selection of potential candidates was carried out based on patients with teeth with surgical indication for orthodontic treatment or with unviable teeth for recovery or reconstruction, or patients wishing to rehabilitate a lost dental piece by placing an implant in the upper premolars area. Patients who meet these criteria were informed about the clinical study. Those who showed interest in participating in the study were redirected to a recruitment interview. During the interview, disease diagnosis and inclusion and exclusion criteria were reviewed, and if the participant was eligible to participate, the information leaflet and the declaration of consent were signed. Specific inclusion and exclusion criteria are listed in Table <xref rid="Tab2" ref-type="table">2</xref>. Twelve male and female adults (above 18 years) were assigned into two groups (Table <xref rid="Tab3" ref-type="table">3</xref>), allocated 6 to each group through a simple randomization methodology, according to the date of acceptance of the patients informed declaration of consent.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Inclusion and exclusion criteria</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Inclusion criteria</th><th align="left">Exclusion criteria</th></tr></thead><tbody><tr><td align="left"><p>✓ Individuals requiring tooth extraction and dental implant replacement, in the upper premolars area</p><p>✓ Skeletally mature individuals, aged between 18 and 65</p><p>✓ Good general health</p></td><td align="left"><p>✗ Individuals with premolars diagnosed with pulp necrosis and chronic endodontic and/or periodontal pathology involving changes in the alveolar bone (except teeth with endodontic pathology without symptoms of inflammatory and/or bacterial origin)</p><p>✗ Accidental avulsion</p><p>✗ Individuals with acute or chronic infections, local or distant from the area to be submitted to surgery</p><p>✗ Women who are pregnant, breastfeeding, or intending to become pregnant during the study</p><p>✗ Individuals with smoking, alcoholic habits, or consumption of illegal substances</p><p>✗ Individuals with medical contraindications (severe kidney disease, malignant tumors, uncontrolled diabetes, vascular or neurological damage, bone or metabolic diseases, patients with prosthetic valves, and immunocompromised individuals)</p><p>✗ Individuals who are engaged to other clinical study or are still covered by a clinical study insurance</p><p>✗ Individuals who demonstrate inability to follow up during the clinical study period</p></td></tr></tbody></table></table-wrap><table-wrap id="Tab3"><label>Table 3</label><caption><p>List of participants</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Patient</th><th align="left">1</th><th align="left">2</th><th align="left">3</th><th align="left">4</th><th align="left">5</th><th align="left">6</th><th align="left">7</th><th align="left">8</th><th align="left">9</th><th align="left">10</th><th align="left">11</th><th align="left">12</th></tr></thead><tbody><tr><td align="left">Sex</td><td align="left">M</td><td align="left">F</td><td align="left">F</td><td align="left">F</td><td align="left">F</td><td align="left">M</td><td align="left">M</td><td align="left">M</td><td align="left">F</td><td align="left">F</td><td align="left">F</td><td align="left">M</td></tr><tr><td align="left">Age</td><td align="left">40<sup>a</sup></td><td align="left">41<sup>b</sup></td><td align="left">66<sup>c</sup></td><td align="left">43<sup>a</sup></td><td align="left">40<sup>b</sup></td><td align="left">48<sup>b</sup></td><td align="left">41<sup>b</sup></td><td align="left">48<sup>b</sup></td><td align="left">51<sup>b</sup></td><td align="left">47<sup>a</sup></td><td align="left">41<sup>b</sup></td><td align="left">48<sup>b</sup></td></tr><tr><td align="left">Tooth</td><td align="left">24</td><td align="left">24</td><td align="left">14</td><td align="left">25</td><td align="left">14</td><td align="left">15</td><td align="left">14</td><td align="left">14</td><td align="left">24</td><td align="left">14</td><td align="left">24</td><td align="left">25</td></tr><tr><td align="left">Group</td><td align="left" colspan="6">DEXGEL Bone (test)</td><td align="left" colspan="6">BL® (control)</td></tr></tbody></table><table-wrap-foot><p><italic>F</italic> female, <italic>M</italic> male, <italic>BL®</italic> Bonelike by Biosckin®</p><p><sup>a</sup>Caries</p><p><sup>b</sup>Tooth/root fracture</p><p><sup>c</sup>Extraction due to periodontal reason</p></table-wrap-foot></table-wrap></p>
              </sec>
              <sec id="Sec5">
                <title>Materials</title>
                <p id="Par15">All reagents used were of the highest degree of purity commercially available, suitable for biopharmaceutical production. Dextrin from Tackidex B 167 (Batch E8747) was kindly provided by Roquette (Lestrem, France), sodium <italic>m‐</italic>periodate (CAS no. 7790‐28‐5) and diethylene glycol (CAS no. 111‐46‐6) were purchased from BIOCHEM Chemopharma (Cosne sur loire, France). Adipic acid dihydrazide (ADH; CAS no. 1071‐93‐8) was supplied by Merck KGaA (Darmstadt, Germany) and endotoxin free phosphate‐buffered saline (PBS; CAS no. 10049‐21‐5) by BioConcept (Allschwil, Switzerland). BL® was provided by Biosckin, Molecular and Cell Therapies, S.A. (Maia, Portugal).</p>
              </sec>
              <sec id="Sec6">
                <title>Preparation of DEXGEL</title>
                <p id="Par16">Dextrin oxidation was performed as previously described [<xref ref-type="bibr" rid="CR32">32</xref>]. Briefly, aqueous solutions of dextrin (2% w/v) were oxidized with sodium <italic>m</italic>‐periodate (NaIO<sub>4</sub>), to yield the theoretical degree of oxidation of 40%, at room temperature, with stirring, in the dark. The oxidation reaction was stopped after 20 h by dropwise addition of an equimolar amount of diethylene glycol to reduce any unreacted periodate. Sodium <italic>m</italic>‐periodate and diethylene glycol were removed by dialysis, using a 1000-Da cutoff membrane (Merck Millipore, Billerica, MA, USA), and then freeze-dried. ODEX was dissolved in PBS solution (30% w/v) and sterilized by gamma irradiation (IONISOS, Dagneux, France), using a <sup>60</sup>Co source, at 20 kGy (2 kGy/h), at room temperature. ADH was also dissolved in PBS solution (3.76% w/v) and sterilized by filtration, using a 0.22-μm pore filter membrane (Pall Corporation, Ann Arbor, MI, USA). For the crosslinking reaction, ODEX and ADH solutions were mixed in a 7:3 volume ratio, respectively. ODEX and ADH were packaged in separate microtubes, vacuum sealed, and stored at 4 °C. Three samples of each were analyzed for endotoxin content by Biogerm, S.A. (Moreira, Portugal) and sterility by Sagilab Laboratório de Análises Técnicas, S.A. Heat-resistant laboratory materials were sterilized by autoclave, and heat-sensitive materials were sterilized by ethylene oxide. The sterilization process and subsequent sterility validation were performed according to the ISO 11137:2006 [<xref ref-type="bibr" rid="CR33">33</xref>] and ISO 11737: 2009 [<xref ref-type="bibr" rid="CR34">34</xref>] requirements, respectively.</p>
              </sec>
              <sec id="Sec7">
                <title>Preparation of BL® granules</title>
                <p id="Par17">BL® was ready in previous commercially available packages. The production procedure has been reported [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR35">35</xref>]. Briefly, phase pure HA was prepared by the precipitation between calcium hydroxide [Ca(OH)<sub>2</sub>] (Prolabo, Paris, France) and orthophosphoric acid 85 wt% [H<sub>3</sub>PO<sub>4</sub>] (Merck, Darmstadt, Germany). Filtered and dried HA precipitate was ground into a fine powder, with a granulometry less than 75 mm. A P<sub>2</sub>O<sub>5</sub>–CaO-based glass with the composition of 65P<sub>2</sub>O<sub>5</sub>–15CaO–10CaF<sub>2</sub>10Na<sub>2</sub>O (mol%) was obtained by mixing the following reagent-grade chemicals: calcium hydrogen phosphate dehydrate (CaHPO<sub>4</sub> · 2H<sub>2</sub>O; Sigma, St. Louis), disodium carbonate (Na<sub>2</sub>CO<sub>3</sub>; Panreac, Spain), calcium fluoride (CaF<sub>2</sub>; Merck, Darmstadt, Germany), and phosphorus pentoxide (P<sub>2</sub>O<sub>5</sub>; Panreac, Spain). A frit was obtained at 1450 °C for 30 min in a platinum crucible. Spherical granules were obtained by mixing 2.5 wt% of glass HA with a pore forming agent, via a dry process, at a rate up to 100 rpm. Then, the mixture was hydrated with purified water and submitted to malaxation. The resulting moist paste was extruded with an extrusion screen of 1 mm (Caleva Extruder 20, Caleva Process Solutions, Blandford, UK) and spheronized (Caleva Spheronizer 120, Caleva Process Solutions, Blandford, UK), and the pellets were then sintered at 1300 °C. Standard sieving techniques were used to obtain the 250–500-µm particle size ranges, displaying an interconnective microporosity structure. BL® was sterilized by gamma irradiation at 25 kGy in Centro de Higienização por Ionização de Produtos S.A., Instituto Tecnológico e Nuclear (Lisboa, Portugal). Table <xref rid="Tab4" ref-type="table">4</xref> shows a summary of the BL® composition.<table-wrap id="Tab4"><label>Table 4</label><caption><p>Composition of BL®</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Material</th><th align="left">Ca/P ratio</th><th align="left">HA (%)</th><th align="left">α-TCP (%)</th><th align="left">β-TCP (%)</th><th align="left">Ions</th><th align="left">Granule size (μm)</th><th align="left">Surface area (m<sup>2</sup>/g)</th><th align="left">Porous size (µm)</th></tr></thead><tbody><tr><td align="left">BL®</td><td char="." align="char">1.70</td><td align="left">81</td><td align="left">17</td><td align="left"> &lt; 2</td><td align="left">Ca<sup>2+</sup>; PO<sub>4</sub><sup>3−</sup></td><td char="–" align="char">250–500</td><td char="." align="char">0.368</td><td char="–" align="char">0.7402–100.35</td></tr></tbody></table><table-wrap-foot><p><italic>Ca/P</italic> calcium/phosphate, <italic>HA</italic> hydroxyapatite, <italic>TCP</italic> tricalcium phosphate, <italic>BL®</italic> Bonelike by Biosckin®</p></table-wrap-foot></table-wrap></p>
              </sec>
              <sec id="Sec8">
                <title>DEXGEL Bone kit</title>
                <p id="Par18">DEXGEL Bone is an injectable, porous, and osteoconductive bone substitute composed of two phases: (i) dextrin hydrogel matrix, DEXGEL — polymeric phase and (ii) BL®, composed mostly of hydroxyapatite, having a percentage of tricalcium phosphate — ceramic phase. The DEXGEL Bone kit is composed of (i) four vials: one with the ODEX solution, another with ADH (both dissolved in PBS) and 2 vials of BL® with 0.5 g each; (ii) a syringe with needle, to transfer ADH solution and subsequent mixing of all components; and (iii) a second syringe to apply the final formulation into the alveolar socket. Components must be mixed at the time of surgery by the medical team, according to a specific protocol (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). Each device was prepared for a final volume of 2 cm<sup>3</sup>, including 0.4 mL of ADH, 0.933 mL of ODEX, and 1 g of BL®. BL® granules, 50% v/v of the total volume of the final formulation (HG), were mixed with the ODEX solution, and the reticulation was achieved adding the ADH solution prior to surgery (Fig. <xref rid="Fig1" ref-type="fig">1</xref>), in a proportion of 7:3 (ODEX:ADH) volume ratio. DEXGEL Bone was ready for administration in a pre-gelled moldable form 5 min upon ADH addition.<fig id="Fig1"><label>Fig. 1</label><caption><p>DEXGEL Bone preparation procedure</p></caption><graphic xlink:href="784_2023_4868_Fig1_HTML" id="MO1"/></fig></p>
                <p id="Par19">Figure <xref rid="Fig2" ref-type="fig">2</xref> shows the necessary time for device handling at the time of surgery, from components mixing to implantation. The preparation was performed by a technician the moment surgeon began the extraction process. Exodontia generally took 5 to 10 min, which matched the time needed for device preparation. After properly gelled in the form of a moldable paste, DEXGEL Bone could be readily implanted or either rest for an extended period of 2 h before implantation, as most convenient to the surgeon. Within this period, the hydrogel matrix did not dehydrate, thus not compromising granule stabilization. Sculpting could be performed from 1 to 2 min. There was no need for a set time within the defect as in other grafting materials, the gum tissue can therefore be closed right after sculpting.<fig id="Fig2"><label>Fig. 2</label><caption><p>Timeline for DEXGEL Bone preparation and handling</p></caption><graphic xlink:href="784_2023_4868_Fig2_HTML" id="MO2"/></fig></p>
              </sec>
              <sec id="Sec9">
                <title>Ethical considerations</title>
                <p id="Par20">iBone Therapies (European Databank on Medical Devices, EUDAMED, No. CIV-PT-18–01-02,705; Protocol No. EC.01.01.17) was previously approved by the Portuguese National Authority of Medicines and Health Products, I.P. (INFARMED), after being submitted in the National Registry of Clinical Studies (RNEC, No. 30122), by the National Ethics Commission for Clinical Research (CEIC, RNEC No. 30121) and National Commission for the Protection of Data (CNPD). The production of DEXGEL was carried out in a clean room with ISO class 4 classification, suitable for the production of medical devices, at the facilities of RESDEVMED Unipessoal Lda (Ovar, Portugal). Qualified candidates were provided all the necessary clarifications so that they could make an informed consciousness decision. Twelve participants provided written informed consent. All participants were covered by a civil liability insurance from Haftpflichtverband der Deutschen Industrie (HDI) company. This study followed CONSORT 2010 statement guidelines for reporting parallel group randomized trials.</p>
              </sec>
              <sec id="Sec10">
                <title>Surgical procedure</title>
                <sec id="Sec11">
                  <title>Tooth extraction and biomaterial implantation</title>
                  <p id="Par21">The surgical intervention was performed by a dentist with experience in oral surgery and implantology at Hospital da Luz Coimbra (Coimbra, Portugal). After CT and X-ray examination, the patient was anesthetized with Artinibsa (articaine + epinephrine at a dosage of 72 mg/1.8 mL + 0.009 mg/1.8 mL, Inibsa Laboratories, Barcelona, Spain). The indicated tooth was extracted, and alveolar curettage was performed for complete removal of injured tissue and tooth remains. DEXGEL Bone was applied using a syringe and sculpted with a spatula, filling the alveolar socket without exceeding alveolar crest. BL® was mixed with autologous blood previously extracted from the alveolar defect and applied with a spatula. Gum tissue was then sutured to end the process. Volunteers were prescribed with ibuprofen 600 mg (Brufen 600, Mylan, Lda., Lisboa, Portugal) from 12 to 12 h for 3 days and amoxicillin 1 g (Cipamox, Laboratórios Vitória, Amadora, Portugal) from 12 to 12 h for 8 days. In case of allergy, azithromycin 500 mg (Zithromax, Pfizer, NY, USA) was prescribed once daily for 3 days.</p>
                </sec>
                <sec id="Sec12">
                  <title>Sample collection and implant placement</title>
                  <p id="Par22">Six months after the extraction, another CT and X-ray were performed to compare with the initial ones. The patient was anesthetized, and the crestal incision was made. A bone sample for histologic analysis purposes was taken with a surgical trephine drill of 3-mm diameter and 10-mm length used vertically in an occlusal-apical direction. After this step, titanium implants were finally placed according to the manufacturer (conical dental implant C1, MIS Implants Technologies Ltd., NC, USA). The wound was closed with a pedicle rotated soft tissue graft from the palate, sutured with a 4–0-thickness PROLENE™ polypropylene suture (Ethicon®, Johnson &amp; Johnson, NJ, USA), and another radiograph was performed. The sequence of major events for a DEXGEL Bone group volunteer is depicted in Fig. <xref rid="Fig3" ref-type="fig">3</xref>.<fig id="Fig3"><label>Fig. 3</label><caption><p>Clinical images illustrating the procedures sequentially ordered from tooth extraction to dental implant placement</p></caption><graphic xlink:href="784_2023_4868_Fig3_HTML" id="MO3"/></fig></p>
                </sec>
              </sec>
              <sec id="Sec13">
                <title>Histological analysis</title>
                <p id="Par23">Histomorphometric analysis was performed at the Hard Tissue Laboratory, Faculty of Medicine, University of Coimbra, Portugal. Bone biopsy samples measuring 6 to 8 mm in length were fixed with 10% formaldehyde (Panreac, Barcelona, Spain) solution buffered at pH 7.4 and stored at 4 °C, until histology analysis of non-decalcified hard tissues with the high-precision Exakt® system (Exakt Technologies, OK, USA). The blocks were sectioned longitudinally in 50–100-μm-thick slices, then stained with toluidine blue and examined with a light microscope (Nikon® Eclipse E600, Tokyo, Japan). The new bone formation, the remaining biomaterial, and the marrow space were quantified in percentages using Bioquant® (Image Analysis Corporation, Nashville, TN).</p>
              </sec>
              <sec id="Sec14">
                <title>Computer tomography</title>
                <p id="Par24">To examine alveolar preservation, CT scans were performed at two time-points: (1) previous to extraction) and (2) after 6 months of biomaterial implantation. Based on an axial section of the upper jaw, the respective curvature was traced, over which radial sections perpendicular to it were obtained, with 1-mm-thick and 1-mm intervals. Also, 1-mm-thick panoramic representations were obtained, one according to the curve mentioned above and also in the palatal and in the vestibular direction with 2-mm intervals.</p>
              </sec>
              <sec id="Sec15">
                <title>Implant Stability Quotient</title>
                <p id="Par25">An Implant Stability Quotient (ISQ) measurement unit was obtained by an advanced non-invasive technique based on resonance frequency analysis, RFA (Penguin RFA, Göteborg, Sweden), commonly used to monitor implant stability. Briefly, a disposable MulTipeg™ (metal transducer with a magnet top) was attached to the implant and magnetically stimulated to vibrate at a micro scale by a handheld probe put closer by 2–4 mm towards the MulTipeg™ top. Then the resonance frequency, i.e., the frequency with the strongest vibration, is measured in a few seconds. Readings were performed from the buccal-lingual and mesial-distal directions. This way, the stiffness of the implant–bone interface was measured and expressed as an ISQ dimensionless value within a scale from 1 to 100, in which the higher the ISQ, the lower the micromotion and the more stable the implant is. Degree of stability can be classified as low for an ISQ &lt; 60, high for an ISQ &gt; 70, and as medium for values in between. ISQ is an objective standard measure reflecting the degree of stability.</p>
              </sec>
              <sec id="Sec16">
                <title>Statistical analysis</title>
                <p id="Par26">In this study, histomorphometry, bone density, bone volume, and primary stability of the implant were compared between test and control groups. Statistical differences in the percentage were assessed by unpaired Student’s <italic>t</italic>-test, and a value of <italic>p</italic> &lt; 0.05 (*) was considered to be significant. Data is presented as mean ± confidence interval (<italic>n</italic> = 6). The normal distribution of the data was assessed by the Shapiro–Wilk test. The analysis was performed using Prism GraphPad 8.02 software® (GraphPad Software, La Jolla, CA, USA). Effect size was measured using Hedges’ <italic>g</italic> formula [<xref ref-type="bibr" rid="CR36">36</xref>].</p>
              </sec>
            </sec>
            <sec id="Sec17">
              <title>Results</title>
              <p id="Par27">The primary endpoint of this study aimed at achieving a volume of bone formed after 6 months equal to the initial post-extraction alveolar volume. As a safety endpoint was the absence of infection and material exposure. A total of 17 volunteers were assessed for eligibility, out of which 5 were excluded for not meeting inclusion criteria described in Table <xref rid="Tab2" ref-type="table">2</xref>. Twelve male and female adults (above 18 years) were randomly assigned into 2 groups of 6 patients each (Table <xref rid="Tab3" ref-type="table">3</xref>). None of the patients discontinued the intervention at any stage of the study (see the CONSORT flow diagram in Fig. <xref rid="Fig4" ref-type="fig">4</xref>).<fig id="Fig4"><label>Fig. 4</label><caption><p>CONSORT flow diagram of this study</p></caption><graphic xlink:href="784_2023_4868_Fig4_HTML" id="MO4"/></fig></p>
              <sec id="Sec18">
                <title>Clinical analysis</title>
                <p id="Par28">One of the aims of this study included evaluating the capability of DEXGEL Bone to mold into the defect and stabilize BL® granules within it. The device fitted and completely filled the alveolar socket, without leakage of the granules (Fig. <xref rid="Fig3" ref-type="fig">3</xref>). DEXGEL Bone displayed improved handling compared to BL® free granules, both during insertion into alveolus and sculpting, operations that were simple to perform and well tolerated by volunteers.</p>
                <p id="Par29">This study was carried out with no signs of local or systemic complications or infection to any volunteer. Patients experienced the usual discomfort associated with oral surgery, with no correlation with grafting material. The sequence of events from exodontia to dental implant placement is shown in Fig. <xref rid="Fig3" ref-type="fig">3</xref>. Six months post-grafting, a 2 mm × 10 mm bone sample was collected, and both DEXGEL Bone and BL® groups exhibited suitable bone density for dental implant placement in alveolus. At this stage, the polymeric matrix had already been reabsorbed and only BL® particulate remains were visible.</p>
              </sec>
              <sec id="Sec19">
                <title>Histological and histomorphometric analysis</title>
                <p id="Par30">A qualitative evaluation of the bone tissue collected 6 months after implantation was performed by observation of toluidine blue–stained slides. Figure <xref rid="Fig5" ref-type="fig">5</xref> shows the representative photomicrographs of the samples collected from each group.<fig id="Fig5"><label>Fig. 5</label><caption><p>Toluidine blue–stained representative photomicrographs of the grafted site 6 months post-implantation: <bold>a</bold> DEXGEL Bone group and <bold>b</bold> BL® group. NB, new bone; BL, BL® remains; CT, connective tissue. Magnification from left to right: <bold>a</bold> 1 × , 3 × , and 10 × ; <bold>b</bold> 1 × , 3 × , and 20 × </p></caption><graphic xlink:href="784_2023_4868_Fig5_HTML" id="MO5"/></fig></p>
                <p id="Par31">Remains of the bone substitute were found in both conditions, in higher amounts in the BL® group. There were no signs of hydrogel after 6 months. New bone was formed on the surfaces and within granules, interspersed with connective tissue. The amount of new bone is notoriously higher in the DEXGEL Bone group. As an important indicator of biocompatibility, no signs of adverse inflammatory reaction were evidenced in both groups. DEXGEL Bone seems to induce a faster new bone regeneration, less unfilled areas being noticed in the histological analysis.</p>
                <p id="Par32">The collected bone sample was also analyzed quantitatively with respect to new bone formation, biomaterial remains, and connective tissue (Fig. <xref rid="Fig6" ref-type="fig">6</xref>). The use of DEXGEL Bone is considered effective since the total bone volume was similar to that of the BL® group (Fig. <xref rid="Fig6" ref-type="fig">6</xref>a). DEXGEL Bone might even be beneficial for bone regeneration since a mean of 49.7% of new bone was reached compared to 32.4% in the BL® group, although the difference is not statistically significant (Fig. <xref rid="Fig6" ref-type="fig">6</xref>b). Higher new bone ingrowth was accompanied by more extensive granule resorption (Fig. <xref rid="Fig6" ref-type="fig">6</xref>c). Connective tissue ingrowth was similar in both groups, 34.0% and 35.6%, respectively (Fig. <xref rid="Fig6" ref-type="fig">6</xref>d). Overall, DEXGEL accelerated BL® reabsorption without compromising (or even stimulating) faster bone growth.<fig id="Fig6"><label>Fig. 6</label><caption><p>Quantitative histomorphometric results of DEXGEL Bone and Bonelike by Biosckin® (BL®) conditions: total bone (<bold>a</bold>), new bone formation (<bold>b</bold>), reminiscent BL® granules (<bold>c</bold>), and connective tissue (<bold>d</bold>) 6 months after implantation. Statistical analysis was performed using Student’s <italic>t</italic>-test (*<italic>p</italic> &lt; 0.05). Results are shown as mean percentages ± confidence interval (<italic>n</italic> = 6). Total bone refers to the sum of new bone with granules</p></caption><graphic xlink:href="784_2023_4868_Fig6_HTML" id="MO6"/></fig></p>
              </sec>
              <sec id="Sec20">
                <title>Bone density and volume</title>
                <p id="Par33">The main application of CT is the preoperative assessment of bone volume and density, providing an important tool for decision-making. Bone density is an important indicator of bone quality for a proper mechanical implant anchorage. Density (HU, Hounsfield units) was analyzed 6 months after biomaterial implantation, prior to implant placement. Five grades were stablished by Misch [<xref ref-type="bibr" rid="CR37">37</xref>] to classify and distinguish bone from the highest to the lowest density: D1 (&gt; 1250 HU), D2 (850 to 1250 HU), D3 (350 to 850 HU), D4 (150 to 350 HU), and D5 (&lt; 150 HU) (Table <xref rid="MOESM1" ref-type="media">2</xref> SI). The DEXGEL Bone group resulted in a slightly lower density (924), compared to BL® (1114), although with no statistical significance for a <italic>p</italic> &lt; 0.05 (Table <xref rid="Tab5" ref-type="table">5</xref>). The mean value of both groups fall into the D2 grade, characterized by porous cortical bone with coarse trabeculae, typically found in the anterior maxilla and the midpalatal region, consistent with the pre-molar area [<xref ref-type="bibr" rid="CR38">38</xref>]. D2 classification is indicative of a high strength bone.<table-wrap id="Tab5"><label>Table 5</label><caption><p>Bone density (HU) of the DEXGEL Bone and BL® groups, for clinician interpretation. Results are shown as mean ± confidence interval (<italic>n</italic> = 6). The differences in bone volume and time-point between the DEXGEL Bone (test) and Bonelike by Biosckin® (BL®, control) groups were analyzed using Student’s <italic>t</italic>-test (<italic>p</italic> &lt; 0.05)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">DEXGEL Bone</th><th align="left">BL®</th></tr></thead><tbody><tr><td align="left">Mean (HU)</td><td align="left">924</td><td align="left">1114</td></tr><tr><td align="left">Standard deviation</td><td align="left">168.44</td><td align="left">125.00</td></tr><tr><td align="left">Range</td><td align="left">721–1145</td><td align="left">997–1267</td></tr><tr><td align="left">Bone quality (Misch [<xref ref-type="bibr" rid="CR37">37</xref>])</td><td align="left">D2</td><td align="left">D2</td></tr><tr><td align="left"><italic>p</italic> value</td><td align="left" colspan="2">0.0516</td></tr></tbody></table><table-wrap-foot><p><italic>BL®</italic> Bonelike by Biosckin®, <italic>HU</italic> Hounsfield units</p></table-wrap-foot></table-wrap></p>
                <p id="Par34">To examine alveolar preservation, initial (post-extraction) bone volume was compared by CT scan to that obtained 6 months after implantation (Fig. <xref rid="Fig7" ref-type="fig">7</xref>). Both groups showed a reduction after 6 months, from 7.73 ± 2.99 to 7.13 ± 2.76 cm<sup>3</sup> in the DEXGEL Bone group, and from 5.32 ± 2.84 to 4.89 ± 2.91 cm<sup>3</sup> in the BL® group, corresponding to a variation mean of − 7.91% and − 9.84%, respectively, although without statistical significance. Nevertheless, results were more favorable to the DEXGEL Bone group. The addition of hydrogel, therefore, did not compromise bone volume formation.<fig id="Fig7"><label>Fig. 7</label><caption><p>Quantitative bone volume results (cm.<sup>3</sup>) obtained from computer tomography (CT) analysis, at the implantation time and after 6 months. Results are shown as mean percentages ± confidence interval (<italic>n</italic> = 6). The differences in bone volume and time-point between the DEXGEL Bone (test) and Bonelike by Biosckin® (BL®, control) groups were analyzed using Student’s <italic>t</italic>-test (*<italic>p</italic> &lt; 0.05)</p></caption><graphic xlink:href="784_2023_4868_Fig7_HTML" id="MO7"/></fig></p>
              </sec>
              <sec id="Sec21">
                <title>Primary stability of the implant</title>
                <p id="Par35">ISQ analysis was used to evaluate primary stability, upon implant placement. The mean ISQ value for the DEXGEL Bone group was 79.7 ± 7.3 and 70.8 ± 2.0 for the BL® group (Fig. <xref rid="Fig8" ref-type="fig">8</xref>). Though the mean values obtained for both groups fall into a high-stability classification (ISQ &gt; 70), the DEXGEL Bone group showed statistically superior stability (<italic>p</italic> = 0.0170). In the DEXGEL Bone group, three out of 6 patients exhibited individual ISQ values from 82 to 90 and none below 70, while in the BL® group no value above 74 was recorded, one individual presenting a value of 68. Therefore, the addition of the hydrogel matrix to BL® granules did not compromise bone quality in terms of stability, apparently being even beneficial for the subsequent restauration. Nevertheless, immediate implant loading with provisional prostheses was not performed in both groups to avoid mechanical pressure. Ten weeks post-implantation, silicon impressions were taken, and at week 13, implants were loaded with the final restoration. No complications were detected during follow-up.<fig id="Fig8"><label>Fig. 8</label><caption><p>Implant Stability Quotient (ISQ) results of the DEXGEL Bone and Bonelike® (BL®) groups, upon dental implant placement. Statistical analysis was performed using Student’s <italic>t</italic>-test (*<italic>p</italic> &lt; 0.05). Results are shown as mean values ± confidence interval (<italic>n</italic> = 6)</p></caption><graphic xlink:href="784_2023_4868_Fig8_HTML" id="MO8"/></fig></p>
                <p id="Par36">Effect size is a quantitative measure of the magnitude of the experimental effect. Measures of 0.2, 0.5, and 0.8 are considered small, medium, and large effect sizes, respectively. Effect size measures below 0.2 may express a negligible difference between two groups, even if statistically significant. Table <xref rid="Tab6" ref-type="table">6</xref> shows the effect size values that show if the treatment had a small, medium, or large effect on the designated outcomes. Compared to the BL® group, DEXGEL Bone exhibited a loss associated with a small effect size in total bone (<italic>g</italic> =  − 0.11) and large in granules (<italic>g</italic> =  − 1.36) and density (<italic>g</italic> =  − 1.18) outcomes, as expressed by the negative Hedges’ <italic>g</italic> value. Effect size measures were also small in the primary outcome for DEXGEL Bone (<italic>g</italic> =  − 0.21) and for BL® (<italic>g</italic> =  − 0.15), suggesting that the difference between the initial bone volume and the same after 6 months is unimportant, as also indicated by <italic>p</italic> &gt; 0.05. Positive Hedges’ <italic>g</italic> expresses a gain associated with a large effect size in respect to new bone (<italic>g</italic> = 1.05) and ISQ (<italic>g</italic> = 1.52) analyses, but small in connective tissue (<italic>g</italic> = 0.11).<table-wrap id="Tab6"><label>Table 6</label><caption><p>Summary of mean and <italic>p</italic> value results, assessing the effect size of each outcome by Hedges’<italic> g</italic> calculations</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"> Outcome</th><th align="left">Mean DEXGEL Bone (test)</th><th align="left">Mean BL® (control)</th><th align="left"><italic>p</italic> value<sup>b</sup></th><th align="left">Hedges’<italic>g</italic><sup>a</sup></th></tr></thead><tbody><tr><td align="left">Total bone (%)</td><td align="left">64.4</td><td align="left">66.0</td><td align="left">0.847</td><td align="left"> − 0.11</td></tr><tr><td align="left">New bone (%)</td><td align="left">49.7</td><td align="left">32.4</td><td align="left">0.076</td><td align="left">1.05</td></tr><tr><td align="left">Granules (%)</td><td align="left">14.7</td><td align="left">33.6</td><td align="left">0.029</td><td align="left"> − 1.36</td></tr><tr><td align="left">Connective tissue (%)</td><td align="left">35.6</td><td align="left">34.0</td><td align="left">0.847</td><td align="left">0.11</td></tr><tr><td align="left">Density (HU)</td><td align="left">924</td><td align="left">1114</td><td align="left">0.052</td><td align="left"> − 1.18</td></tr><tr><td align="left">ISQ</td><td align="left">79.7</td><td align="left">70.8</td><td align="left">0.017</td><td align="left">1.52</td></tr><tr><td align="left"/><td align="left"> Mean (after 6 months)</td><td align="left">Mean (initial)</td><td align="left"> <italic>p</italic> value<sup>b</sup></td><td align="left">Hedges’ <italic>g</italic><sup>c</sup></td></tr><tr><td align="left">Bone volume (cm<sup>3</sup>) for DEXGEL Bone</td><td align="left">7.13</td><td align="left">7.73</td><td align="left">0.722</td><td align="left">0.19</td></tr><tr><td align="left">Bone volume (cm<sup>3</sup>) for BL®</td><td align="left">4.89</td><td align="left">5.32</td><td align="left">0.803</td><td align="left">0.14</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup>The effect size was estimated by the difference (test–control) in mean change in the specified outcome measurement and represents the gain associated with treatment</p><p><sup>b</sup>Significance probability associated with the Student’s <italic>t</italic>-test performed to compare the means of test and control (*<italic>p</italic> &lt; 0.05)</p><p><sup>c</sup>The effect size was estimated by the difference (after–initial) in mean change in the specified outcome measurement and represents the gain associated with the 6-month time-point</p></table-wrap-foot></table-wrap></p>
                <p id="Par37">Despite a non-significant <italic>p</italic>-value, new bone and density outcomes show large effect sizes, being indicative of an advantageous stimulus to the regenerative process provided by DEXGEL Bone. The significant <italic>p</italic>-values of granule quantification and ISQ are reinforced by large effect sizes, and non-significant <italic>p</italic>-values are reinforced by a low effect size for total bone, connective tissue, and bone volume after 6 months.</p>
              </sec>
            </sec>
            <sec id="Sec22">
              <title>Discussion</title>
              <p id="Par38">This is the first-in-human study of DEXGEL Bone on safety and efficacy. No local or systemic complications or infections were identified, and none of the participants were excluded from the study. A synthetic bone substitute, BL® (control), was compared to its hydrogel-reinforced version, DEXGEL Bone (test), in the preservation of the alveolar ridge dimensions following tooth extraction. Six months after exodonty and grafting, CT scans showed healed bone defects in both groups, suitable for bone sample collection and dental implant placement. The implants were eventually loaded with prostheses, generally 13 weeks post-implantation. Major outcomes of this study include handling properties, safety validation, assessment of bone quantity and quality, and primary stability of implant.</p>
              <p id="Par39">From a commercial point of view, an extended shelf-life is important for any product. However, extended stability studies on hydrogels for biomedical applications are scarce in literature. The reticulation of DEXGEL is driven by covalent interactions between ODEX aldehydes and ADH amines, and gelation time can be manipulated to vary between a few seconds to several hours, depending on ODEX and ADH concentrations or on the oxidation degree [<xref ref-type="bibr" rid="CR12">12</xref>]. Thus, a reduction in the content of reactive groups induced by any structural modifications, such as degradation, would interfere with the gelation period. We performed a gelation study using sterilized ODEX and ADH solutions stored at 4 °C for up to 3 years. The term “gelation” here refers to the moment when it was no longer possible to pipette the hydrogel — which is the relevant form for clinical handling — irrespective of crosslinking extent reactions. The gelling time (30 s) of an ODEX mixture, prepared with fresh ADH, did not suffer any changes up to 3 years, demonstrating an excellent stability (Table <xref rid="MOESM1" ref-type="media">1</xref> SI).</p>
              <p id="Par40">Stability and conformability are of particular importance, to avoid the release or migration of particles, assess difficult sites, mold to the defect, and provide a reproducible and homogeneous mixing procedure convenient to the surgeon. Synthetic bone substitutes are now available in different forms, though with some shortcomings on handling properties. For instance, granules can migrate out of the defect during and after surgery; microporous blocks may be difficult to fit within the defect; and cement paste might set too fast and, similar to putty, can be poorly injectable [<xref ref-type="bibr" rid="CR39">39</xref>]. The addition of DEXGEL to BL® improved granule cohesivity, by turning it into a moldable paste-like material, easy to administer with a syringe in the maxillary alveolar socket of the pre-molar area, avoiding granule leakage until wound closure. DEXGEL Bone is neither too liquid nor to viscous; therefore, extrusion force was suitable as to provide an easy control of biomaterial outflow from the syringe opening [<xref ref-type="bibr" rid="CR18">18</xref>]. BL® granules (mixed with autologous blood), on the other hand, had to be administered with a spatula and were prone to leakage during socket loading. Since DEXGEL is produced separately from the bone substitute, combinations with other commercially available grafting materials can be considered. DEXGEL is able to pass through a needle (injectability), with the diameter of the opening being limited by the size of the particles to which it is combined. The association of this HG to a particulate bone substitute would enable further loading of molecules with bone healing or antimicrobial properties.</p>
              <p id="Par41">Clinically, no complications were observed and all participants healed normally. Histologically, both test and control groups showed good integration of grafting material into newly formed bone and were biologically compatible with the host tissues, showing no signs of adverse reaction. Photomicrographs confirmed the formation of vascularized mature bone and soft tissue matrix, confirming the osteoconductive character of both test and control groups. A considerably lower number of granules were visible in the test group, interspaced by a thicker new bone formation, as compared to the control group. In accordance with histologic observations, histomorphometric examination showed DEXGEL-accelerated BL® reabsorption without compromising total bone growth, as we have previously shown in the regeneration of critical-sized defects in a goat model [<xref ref-type="bibr" rid="CR17">17</xref>]. The higher rate of BL® granule resorption may have opened up space for more new bone ingrowth in the DEXGEL Bone group. The balance between resorption of a scaffold and its replacement by new bone formation is a key factor to shorten bone healing time. The addition of DEXGEL to BL® apparently optimized this balance. This higher resorption effect may be explained by the acidic character provided by aldehyde-bearing ODEX. The pH of the ODEX solution around 3.0 increases to 4.7 after adding BL® granules in the first step of biomaterial preparation. The subsequent addition of ADH solution (pH = 7.4) further increases pH of the final formulation to 5.2. After implantation, the more soluble TCP phase is prone to a faster resorption rate than HA [<xref ref-type="bibr" rid="CR40">40</xref>], which can be considerably accelerated by pH acidification [<xref ref-type="bibr" rid="CR41">41</xref>].</p>
              <p id="Par42">Ideally, scaffold materials should degrade synchronously as new bone ingrowth takes place, without loss of mechanical support. As the bone regeneration process takes place, BL® is also resorbed in a slow and controlled manner, contributing to the natural remodeling of the bone [<xref ref-type="bibr" rid="CR42">42</xref>]. BL® is composed by a modified HA (≥ 50%) matrix, TCP, and ionic species commonly found in human bone, i.e., magnesium, sodium, and fluor (≤ 50%). The addition of the TCP phase confers a degradability character to the non-degradable hydroxyapatite (HA) [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR43">43</xref>]. The TCP resorption mechanism is essentially cell-mediated [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR44">44</xref>]: bone remodeling cells, osteoclasts, release hydrochloric acid at the material surface, inducing calcium phosphate dissolution by acidification [<xref ref-type="bibr" rid="CR45">45</xref>]. Polymer-based bone graft substitutes are resorbed by hydrolysis [<xref ref-type="bibr" rid="CR39">39</xref>]. The reversibility nature of ADH and ODEX crosslinking [<xref ref-type="bibr" rid="CR14">14</xref>] gradually releases 1–4 α-linked glucose dextrin, which can be enzymatically decomposed by blood α-amylases [<xref ref-type="bibr" rid="CR46">46</xref>]. Dextrin and its degradation products can be metabolized or undergo renal elimination, owing to its low molecular weight (~ 2 kDa for Tackidex® B 167) below the renal filtration limit range (~ 30–50 kDa) [<xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR47">47</xref>]. Overall, DEXGEL Bone resorption can occur by several ways such as dissolution, cell-mediated dissolution, hydrolysis, and enzymatic decomposition.</p>
              <p id="Par43">Despite the favorable biodegradability, the use of polymeric bone grafters is restricted by limitations related to acidic degradation products that may accelerate implant deterioration and induce inflammatory reactions with negative implications for tissue repair [<xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR49">49</xref>]. In this study, DEXGEL was not detected 6 months post-treatment prior to implant placement, neither has it ever been detected in previous pre-clinical studies from three weeks on [<xref ref-type="bibr" rid="CR16">16</xref>–<xref ref-type="bibr" rid="CR18">18</xref>]. Interference with implants would not therefore be a concern. The HG improved the granule cohesivity and ease of handling at the time of administration, as intended (injectability and mouldability), then being fully resorbed rapidly, opening up space for more new bone growth.</p>
              <p id="Par44">The success of dental implant placement relies on both the alveolar bone volume and density. The first may allow implant placement in the three-dimensionally correct position or, on the contrary, prevent its placement due to inadequate bone dimensions. In this latter case, a second-regeneration treatment simultaneously with implant placement may be considered. The second may essentially influence the primary stability of the implant, its osseointegration, and the timing of prostheses loading. Human studies on dimensional changes of undisturbed alveolar natural healing have reported horizontal bone loss of 29–63% and vertical bone loss of 11–22% at 6 months post-extraction [<xref ref-type="bibr" rid="CR50">50</xref>]. In this work, we report bone volume variation means of − 7.91% and − 9.84% for the test and control groups, respectively. The addition of HG showed no constraints on this parameter. Bone density could be defined as the amount of bone filling within a certain bone volume, being indicative of bone ability to ensure proper mechanical attachment of an implant [<xref ref-type="bibr" rid="CR51">51</xref>]. Indeed, primary retention is achieved by mechanical means rather than through osseointegration. Implants on low-density bone are more likely to fail [<xref ref-type="bibr" rid="CR52">52</xref>]. In our study, DEXGEL Bone did not compromise the regeneration process, evidencing a good-quality bone with a density classification of D2 (Misch [<xref ref-type="bibr" rid="CR37">37</xref>]), the typical structural conformation of a common pre-molar tooth region [<xref ref-type="bibr" rid="CR38">38</xref>]. With respect to strength, D1 and D4 bones are spaced by a tenfold difference, in which, if converted to a scale of 1 to 10 from the least to the greatest strength, D1 could be seen as a 9 or 10, D2 a 7 or 8, D3 a 3 or 4, and D4 a 1 or 2 [<xref ref-type="bibr" rid="CR37">37</xref>]. Implant failure has been reported as 5% in D1 bone, 2.2% in D2, 13.6% in D3 and 19.2% in D4 [<xref ref-type="bibr" rid="CR53">53</xref>]. While a healing period of 3 to 4 months would be adequate for D1 and D2 before implant loading, 5 to 6 months would be required for D3 and D4.</p>
              <p id="Par45">ISQ can ultimately determine whether or not the implant will withstand the impact of a provisional or a final restauration, and the subsequent mechanical impact from masticatory forces when integrated in the overall dentition. ISQ is, therefore, important for decision-making during implant treatment and follow-up [<xref ref-type="bibr" rid="CR54">54</xref>]. Although both conditions occasioned an excellent ISQ mean (&gt; 70) at implant placement, administration of DEXGEL Bone generally resulted in a higher primary stability of dental implant, indicating that the presence of DEXGEL did not compromise immediate osseointegration, being even advantageous. In these cases, immediate implant loading is accepted. A higher ISQ value may be explained by the higher tendency for more new bone ingrowth, as a positive linear correlation between both has been reported [<xref ref-type="bibr" rid="CR51">51</xref>]. ISQ values were high even for hydroxyapatites grafted sites [<xref ref-type="bibr" rid="CR55">55</xref>]. ISQ changes over time are reported in many studies, describing an initial decline lasting from up to the first 2 weeks to 3 months, followed by a gradual increase up to higher or similar values to the original one [<xref ref-type="bibr" rid="CR56">56</xref>]. Therefore, although ISQ evaluation taken later at restoration placement (secondary stability) seems more important for success predictability than at implant placement (primary stability) [<xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR58">58</xref>], initial ISQ values of this study may nevertheless be indicative of implant clinical success. These results further indicate that DEXGEL Bone would possibly enable the earlier placement of a final prosthesis, shortening the conventional period of 3 to 6 months, improving the life quality of the patient. This study also confirms that changing the physicochemical properties of a bone substitute material can influence implant stability.</p>
              <p id="Par46">In this study, we used the 250–500-µm spherical BL® which has shown to induce a slightly faster bone regeneration than 500–1000 µm [<xref ref-type="bibr" rid="CR42">42</xref>]. The presence of adequate pore dimension in BL® favors osteointegration, osteoconduction, and degradation, allowing bone ingrowth in the interspaces, as it enables blood vessels and cell infiltration, exchange of proteins and nutrients, and waste clearance. Overall, BL® provides an ideal environment for bone adhesion, cell proliferation, and differentiation; has a slow and controlled resorption; and contributes to natural bone remodeling. DEXGEL provides an easy and effective filling of bone defects according to its irregularities, given its excellent handling and molding properties. It was rapidly resorbed and accelerated BL® resorption as well, freeing up space that favored new bone ingrowth, without compromising mechanical support. The small population size is a limitation of this study, which however was adequate to prove the safety of this HG in its first contact with humans. Larger samples can now be considered in future studies. The present study validates DEXGEL Bone suitability for oral rehabilitation with endosseous implants, although other clinical scenarios may be considered.</p>
            </sec>
            <sec id="Sec23">
              <title>Conclusion</title>
              <p id="Par47">DEXGEL Bone is a moldable, easy-to-apply bone regeneration optimized technology that naturally stimulates bone formation. The addition of DEXGEL to BL® granules provided the biomaterial with injectability without compromising bone volume nor density. DEXGEL Bone even showed a tendency for more new bone formation and maximized primary stability of the dental implant, which have reported a positive correlation. A clinical benefit is therefore achieved: improved granule cohesivity, easier handling, delivering (injectability), and sculpting of the biomaterial within the alveolar socket. DEXGEL Bone did not cause pain, discomfort, or infections, being effective in alveolar ridge preservation. DEXGEL is easy to produce, is cost-effective, has a long-shelf life, and can provide benefits to commercially available grafting materials in terms of injectability, moldability, and clinical performance. This in situ gelling HG further provides a platform for the entrapment of specific therapeutic agents to meet other clinical scenarios. Some conclusions of this study may be limited by a small population size, which however was adequate for the first human safety assessment. Now with safety validation, larger populations could be considered in the future.
</p>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Supplementary Information</title>
              <sec id="Sec24">
                <p>Below is the link to the electronic supplementary material.<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="784_2023_4868_MOESM1_ESM.docx"><caption><p>Supplementary file1 (DOCX 288 KB)</p></caption></media></supplementary-material></p>
              </sec>
            </sec>
          </body>
          <back>
            <fn-group>
              <fn>
                <p>
                  <bold>Publisher's Note</bold>
                </p>
                <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
              </fn>
            </fn-group>
            <ack>
              <p>The authors acknowledge Hospital da Luz, Coimbra, for its partnership in conducting this clinical study.</p>
            </ack>
            <notes notes-type="author-contribution">
              <title>Author contribution</title>
              <p>The first draft of the manuscript was written by Alexandra Machado, and all authors read and approved the final manuscript. Specific contributions were made by each author: conceptualization, Isabel Pereira, Filomena Costa, Ana Brandão, Ana Colette Maurício, José Domingos Santos, Rui Coelho and Miguel Gama; methodology, Alexandra Machado, Isabel Pereira, Inês Amaro and Nuno Cruz; validation, Isabel Pereira, Filomena Costa, Ana Brandão, Ana Colette Maurício, José Domingos Santos, Rui Falacho, Rui Coelho and Miguel Gama; formal analysis, Alexandra Machado and Isabel Pereira; investigation, Alexandra Machado, Isabel Pereira, Filomena Costa, Inês Amaro and Nuno Cruz; resources Ana Brandão, Ana Colette Maurício, José Domingos Santos and Miguel Gama; writing—original draft preparation, Alexandra Machado; writing—review and editing, Isabel Pereira, Nuno Cruz and Miguel Gama; supervision, Isabel Pereira, Inês Amaro, Rui Coelho, Nuno Cruz and Miguel Gama; project administration, Ana Brandão, Ana Colette Maurício, José Domingos Santos, José Eduardo Pereira, Inês Amaro, Rui Coelho, Nuno Cruz and Miguel Gama; funding acquisition, Ana Brandão, Ana Colette Maurício, José Domingos Santos, Nuno Cruz and Miguel Gama. Surgical procedure, examination, and data recording were performed by Nuno Cruz and Inês Amaro.</p>
            </notes>
            <notes notes-type="funding-information">
              <title>Funding
</title>
              <p>Open access funding provided by FCT|FCCN (b-on). The authors were funded by FEDER and NORTE 2020 through project no. 003262 titled “iBONE therapies: advanced solutions for bone regeneration.” This study was supported by the Portuguese Foundation for Science and Technology (FCT) under the scope of the strategic funding of the UID/BIO/04469 unit and COMPETE 2020 (POCI-01–0145-FEDER-006684) and BioTecNorte operation (NORTE-01–0145-FEDER-000004) funded by the European Regional Development Fund under the scope of Norte 2020—Programa Operacional Regional do Norte. The authors were granted a scholarship (SFRH/BD/132000/2017) by Portuguese FCT. This work was also funded by project UIDB/CVT/00772/2020 supported by FCT.</p>
            </notes>
            <notes notes-type="data-availability">
              <title>Data Availability</title>
              <p>Data available within the article or its supplementary materials.</p>
            </notes>
            <notes>
              <title>Declarations</title>
              <notes id="FPar1">
                <title>Ethics approval</title>
                <p id="Par48">All procedures performed in this study involving human participants were in accordance with the ethical standards of the Portuguese INFARMED and with the 1964 Helsinki Declaration or comparable ethical standards. iBone Therapies (European Databank on Medical Devices, EUDAMED, No. CIV-PT-18–01-02705; Protocol No. EC.01.01.17) was previously approved by the Portuguese National Authority of Medicines and Health Products, I.P. (INFARMED), after being submitted in the National Registry of Clinical Studies (RNEC, No. 30122), by the National Ethics Commission for Clinical Research (CEIC, RNEC No. 30121) and National Commission for the Protection of Data (CNPD).</p>
              </notes>
              <notes id="FPar2">
                <title>Consent to participate and to publish</title>
                <p id="Par49">Informed consent was obtained from all individual participants included in the study. Research participants also provided informed consent regarding the publication of every information included in the present manuscript.</p>
              </notes>
              <notes id="FPar3" notes-type="COI-statement">
                <title>Conflict of interest</title>
                <p id="Par50">The authors declare no competing interests.</p>
              </notes>
            </notes>
            <ref-list id="Bib1">
              <title>References</title>
              <ref id="CR1">
                <label>1.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Couso-Queiruga</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Stuhr</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Tattan</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Chambrone</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Avila-Ortiz</surname>
                      <given-names>G</given-names>
                    </name>
                  </person-group>
                  <article-title>Post-extraction dimensional changes: a systematic review and meta-analysis</article-title>
                  <source>J Clin Periodontol</source>
                  <year>2021</year>
                  <volume>48</volume>
                  <fpage>127</fpage>
                  <lpage>145</lpage>
                  <pub-id pub-id-type="doi">10.1111/JCPE.13390</pub-id>
                </element-citation>
              </ref>
              <ref id="CR2">
                <label>2.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Khojasteh</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Kheiri</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Motamedian</surname>
                      <given-names>SR</given-names>
                    </name>
                    <name>
                      <surname>Khoshkam</surname>
                      <given-names>V</given-names>
                    </name>
                  </person-group>
                  <article-title>Guided bone regeneration for the reconstruction of alveolar bone defects</article-title>
                  <source>Ann Maxillofac Surg</source>
                  <year>2017</year>
                  <volume>7</volume>
                  <fpage>263</fpage>
                  <pub-id pub-id-type="doi">10.4103/AMS.AMS_76_17</pub-id>
                  <?supplied-pmid 29264297?>
                  <pub-id pub-id-type="pmid">29264297</pub-id>
                </element-citation>
              </ref>
              <ref id="CR3">
                <label>3.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Iviglia</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Cassinelli</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Torre</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Baino</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Morra</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Vitale-Brovarone</surname>
                      <given-names>C</given-names>
                    </name>
                  </person-group>
                  <article-title>Novel bioceramic-reinforced hydrogel for alveolar bone regeneration</article-title>
                  <source>Acta Biomater</source>
                  <year>2016</year>
                  <volume>44</volume>
                  <fpage>97</fpage>
                  <lpage>109</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.actbio.2016.08.012</pub-id>
                  <?supplied-pmid 27521494?>
                  <pub-id pub-id-type="pmid">27521494</pub-id>
                </element-citation>
              </ref>
              <ref id="CR4">
                <label>4.</label>
                <mixed-citation publication-type="other">Barbeck M, Jung O, Smeets R, Gosau M, Schnettler R, Rider P, Houshmand A, Korzinskas T (2020) Implantation of an injectable bone substitute material enables integration following the principles of guided bone regeneration. In Vivo (Brooklyn) 34:557–568. 10.21873/INVIVO.11808</mixed-citation>
              </ref>
              <ref id="CR5">
                <label>5.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Flegeau</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Gauthier</surname>
                      <given-names>O</given-names>
                    </name>
                    <name>
                      <surname>Rethore</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Autrusseau</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Schaefer</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Lesoeur</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Veziers</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Brésin</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Gautier</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Weiss</surname>
                      <given-names>P</given-names>
                    </name>
                  </person-group>
                  <article-title>Injectable silanized hyaluronic acid hydrogel/biphasic calcium phosphate granule composites with improved handling and biodegradability promote bone regeneration in rabbits</article-title>
                  <source>Biomater Sci</source>
                  <year>2021</year>
                  <volume>9</volume>
                  <fpage>5640</fpage>
                  <lpage>5651</lpage>
                  <pub-id pub-id-type="doi">10.1039/D1BM00403D</pub-id>
                  <?supplied-pmid 34254604?>
                  <pub-id pub-id-type="pmid">34254604</pub-id>
                </element-citation>
              </ref>
              <ref id="CR6">
                <label>6.</label>
                <mixed-citation publication-type="other">Gama M, Molinos M (2011) Dextrin hydrogel for biomedical applications. WO/2011/070529A2.</mixed-citation>
              </ref>
              <ref id="CR7">
                <label>7.</label>
                <mixed-citation publication-type="other">Food And Drugs. Code of Federal Regulations, title 21 (2021), Chapter I, Subchapter B, Part 184, Subpart B §184.1277. <ext-link ext-link-type="uri" xlink:href="https://www.ecfr.gov/current/title-21/chapter-I/subchapter-B/part-184">https://www.ecfr.gov/current/title-21/chapter-I/subchapter-B/part-184</ext-link></mixed-citation>
              </ref>
              <ref id="CR8">
                <label>8.</label>
                <mixed-citation publication-type="other">Gonçalves C, Moreira SM, Carvalho V, Silva DM, Gama M (2016) Dextrin. In: Mishra M (ed) Encycl. Biomed. Polym. Polym. Biomater., 1st ed. CRC Press, New York, pp 2634–2649</mixed-citation>
              </ref>
              <ref id="CR9">
                <label>9.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Carvalho</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Moreira</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Maia</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Gama</surname>
                      <given-names>FM</given-names>
                    </name>
                  </person-group>
                  <article-title>Characterization of dextrin-based hydrogels: rheology, biocompatibility, and degradation</article-title>
                  <source>J Biomed Mater Res A</source>
                  <year>2010</year>
                  <volume>93</volume>
                  <fpage>389</fpage>
                  <lpage>399</lpage>
                  <pub-id pub-id-type="doi">10.1002/JBM.A.32553</pub-id>
                  <?supplied-pmid 19569221?>
                  <pub-id pub-id-type="pmid">19569221</pub-id>
                </element-citation>
              </ref>
              <ref id="CR10">
                <label>10.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Carvalho</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Gonçalves</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Gil</surname>
                      <given-names>AM</given-names>
                    </name>
                    <name>
                      <surname>Gama</surname>
                      <given-names>FM</given-names>
                    </name>
                  </person-group>
                  <article-title>Production and characterization of a new dextrin based hydrogel</article-title>
                  <source>Eur Polym J</source>
                  <year>2007</year>
                  <volume>43</volume>
                  <fpage>3050</fpage>
                  <lpage>3059</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.eurpolymj.2007.02.046</pub-id>
                </element-citation>
              </ref>
              <ref id="CR11">
                <label>11.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Das</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Pal</surname>
                      <given-names>S</given-names>
                    </name>
                  </person-group>
                  <article-title>Modified biopolymer-dextrin based crosslinked hydrogels: application in controlled drug delivery</article-title>
                  <source>RSC Adv</source>
                  <year>2015</year>
                  <volume>5</volume>
                  <fpage>25014</fpage>
                  <lpage>25050</lpage>
                  <pub-id pub-id-type="doi">10.1039/C4RA16103C</pub-id>
                </element-citation>
              </ref>
              <ref id="CR12">
                <label>12.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Molinos</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Carvalho</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Silva</surname>
                      <given-names>DM</given-names>
                    </name>
                    <name>
                      <surname>Gama</surname>
                      <given-names>FM</given-names>
                    </name>
                  </person-group>
                  <article-title>Development of a hybrid dextrin hydrogel encapsulating dextrin nanogel as protein delivery system</article-title>
                  <source>Biomacromol</source>
                  <year>2012</year>
                  <volume>13</volume>
                  <fpage>517</fpage>
                  <lpage>527</lpage>
                  <pub-id pub-id-type="doi">10.1021/bm2015834</pub-id>
                </element-citation>
              </ref>
              <ref id="CR13">
                <label>13.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Xu</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Hsu</surname>
                      <given-names>S</given-names>
                    </name>
                  </person-group>
                  <article-title>Hydrogels based on Schiff base linkages for biomedical applications</article-title>
                  <source>Molecules</source>
                  <year>2019</year>
                  <volume>24</volume>
                  <fpage>3005</fpage>
                  <pub-id pub-id-type="doi">10.3390/MOLECULES24163005</pub-id>
                  <?supplied-pmid 31430954?>
                  <pub-id pub-id-type="pmid">31430954</pub-id>
                </element-citation>
              </ref>
              <ref id="CR14">
                <label>14.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zhang</surname>
                      <given-names>Z</given-names>
                    </name>
                    <name>
                      <surname>He</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>X</given-names>
                    </name>
                  </person-group>
                  <article-title>Hydrogels based on pH-responsive reversible carbon–nitrogen double-bond linkages for biomedical applications</article-title>
                  <source>Mater Chem Front</source>
                  <year>2018</year>
                  <volume>2</volume>
                  <fpage>1765</fpage>
                  <lpage>1778</lpage>
                  <pub-id pub-id-type="doi">10.1039/C8QM00317C</pub-id>
                </element-citation>
              </ref>
              <ref id="CR15">
                <label>15.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Silva</surname>
                      <given-names>DM</given-names>
                    </name>
                    <name>
                      <surname>Nunes</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Pereira</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Moreira</surname>
                      <given-names>ASP</given-names>
                    </name>
                    <name>
                      <surname>Domingues</surname>
                      <given-names>MRM</given-names>
                    </name>
                    <name>
                      <surname>Coimbra</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Gama</surname>
                      <given-names>FM</given-names>
                    </name>
                  </person-group>
                  <article-title>Structural analysis of dextrins and characterization of dextrin-based biomedical hydrogels</article-title>
                  <source>Carbohydr Polym</source>
                  <year>2014</year>
                  <volume>114</volume>
                  <fpage>458</fpage>
                  <lpage>466</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.carbpol.2014.08.009</pub-id>
                  <?supplied-pmid 25263914?>
                  <pub-id pub-id-type="pmid">25263914</pub-id>
                </element-citation>
              </ref>
              <ref id="CR16">
                <label>16.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Silva</surname>
                      <given-names>DM</given-names>
                    </name>
                    <name>
                      <surname>Caseiro</surname>
                      <given-names>AR</given-names>
                    </name>
                    <name>
                      <surname>Amorim</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Pereira</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Faria</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Pereira</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Santos</surname>
                      <given-names>JD</given-names>
                    </name>
                    <name>
                      <surname>Gama</surname>
                      <given-names>FM</given-names>
                    </name>
                    <name>
                      <surname>Maurício</surname>
                      <given-names>AC</given-names>
                    </name>
                  </person-group>
                  <article-title>Inflammatory response to dextrin-based hydrogel associated with human mesenchymal stem cells, urinary bladder matrix and Bonelike ® granules in rat subcutaneous implants</article-title>
                  <source>Biomed Mater</source>
                  <year>2016</year>
                  <volume>11</volume>
                  <fpage>065004</fpage>
                  <pub-id pub-id-type="doi">10.1088/1748-6041/11/6/065004</pub-id>
                  <?supplied-pmid 27786165?>
                  <pub-id pub-id-type="pmid">27786165</pub-id>
                </element-citation>
              </ref>
              <ref id="CR17">
                <label>17.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pereira</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Pereira</surname>
                      <given-names>JE</given-names>
                    </name>
                    <name>
                      <surname>Maltez</surname>
                      <given-names>L</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Regeneration of critical-sized defects, in a goat model, using a dextrin-based hydrogel associated with granular synthetic bone substitute</article-title>
                  <source>Regen Biomater</source>
                  <year>2021</year>
                  <volume>8</volume>
                  <fpage>1</fpage>
                  <lpage>10</lpage>
                  <pub-id pub-id-type="doi">10.1093/rb/rbaa036</pub-id>
                </element-citation>
              </ref>
              <ref id="CR18">
                <label>18.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pereira</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Fraga</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Maltez</surname>
                      <given-names>L</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>In vivo systemic toxicity assessment of an oxidized dextrin-based hydrogel and its effectiveness as a carrier and stabilizer of granular synthetic bone substitutes</article-title>
                  <source>J Biomed Mater Res Part A</source>
                  <year>2019</year>
                  <volume>107</volume>
                  <fpage>1678</fpage>
                  <lpage>1689</lpage>
                  <pub-id pub-id-type="doi">10.1002/jbm.a.36683</pub-id>
                </element-citation>
              </ref>
              <ref id="CR19">
                <label>19.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pereira</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Fraga</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Silva</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Teixeira</surname>
                      <given-names>JP</given-names>
                    </name>
                    <name>
                      <surname>Gama</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>In vitro genotoxicity assessment of an oxidized dextrin-based hydrogel for biomedical applications</article-title>
                  <source>J Appl Toxicol</source>
                  <year>2019</year>
                  <volume>39</volume>
                  <fpage>639</fpage>
                  <lpage>649</lpage>
                  <pub-id pub-id-type="doi">10.1002/jat.3754</pub-id>
                  <?supplied-pmid 30485472?>
                  <pub-id pub-id-type="pmid">30485472</pub-id>
                </element-citation>
              </ref>
              <ref id="CR20">
                <label>20.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wang</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Yeung</surname>
                      <given-names>KWK</given-names>
                    </name>
                  </person-group>
                  <article-title>Bone grafts and biomaterials substitutes for bone defect repair: a review</article-title>
                  <source>Bioact Mater</source>
                  <year>2017</year>
                  <volume>2</volume>
                  <fpage>224</fpage>
                  <lpage>247</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.bioactmat.2017.05.007</pub-id>
                  <?supplied-pmid 29744432?>
                  <pub-id pub-id-type="pmid">29744432</pub-id>
                </element-citation>
              </ref>
              <ref id="CR21">
                <label>21.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Papageorgiou</surname>
                      <given-names>SN</given-names>
                    </name>
                    <name>
                      <surname>Papageorgiou</surname>
                      <given-names>PN</given-names>
                    </name>
                    <name>
                      <surname>Deschner</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Götz</surname>
                      <given-names>W</given-names>
                    </name>
                  </person-group>
                  <article-title>Comparative effectiveness of natural and synthetic bone grafts in oral and maxillofacial surgery prior to insertion of dental implants: systematic review and network meta-analysis of parallel and cluster randomized controlled trials</article-title>
                  <source>J Dent</source>
                  <year>2016</year>
                  <volume>48</volume>
                  <fpage>1</fpage>
                  <lpage>8</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.jdent.2016.03.010</pub-id>
                  <?supplied-pmid 27012858?>
                  <pub-id pub-id-type="pmid">27012858</pub-id>
                </element-citation>
              </ref>
              <ref id="CR22">
                <label>22.</label>
                <mixed-citation publication-type="other">Santos JD, Lopes MA, Silva MA (2008) Hydroxyapatite and bioglass-based pellets, production process and applications of thereof. EP2349361A1</mixed-citation>
              </ref>
              <ref id="CR23">
                <label>23.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Duarte</surname>
                      <given-names>F</given-names>
                    </name>
                    <name>
                      <surname>Santos</surname>
                      <given-names>JD</given-names>
                    </name>
                    <name>
                      <surname>Afonso</surname>
                      <given-names>A</given-names>
                    </name>
                  </person-group>
                  <article-title>Medical applications of Bonelike® in maxillofacial surgery</article-title>
                  <source>Mater Sci Forum</source>
                  <year>2004</year>
                  <volume>455–456</volume>
                  <fpage>370</fpage>
                  <lpage>373</lpage>
                  <pub-id pub-id-type="doi">10.4028/www.scientific.net/MSF.455-456.370</pub-id>
                </element-citation>
              </ref>
              <ref id="CR24">
                <label>24.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gutierres</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Sooraj Hussain</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Afonso</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Almeida</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Cabral</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Lopes</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Santos</surname>
                      <given-names>JD</given-names>
                    </name>
                  </person-group>
                  <article-title>Biological behaviour of Bonelike® graft implanted in the tibia of humans</article-title>
                  <source>Key Eng Mater</source>
                  <year>2005</year>
                  <volume>284–286</volume>
                  <fpage>1041</fpage>
                  <lpage>1044</lpage>
                  <pub-id pub-id-type="doi">10.4028/www.scientific.net/KEM.284-286.1041</pub-id>
                </element-citation>
              </ref>
              <ref id="CR25">
                <label>25.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gutierres</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Hussain</surname>
                      <given-names>NS</given-names>
                    </name>
                    <name>
                      <surname>Lopes</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Afonso</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Cabral</surname>
                      <given-names>AT</given-names>
                    </name>
                    <name>
                      <surname>Almeida</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Santos</surname>
                      <given-names>JD</given-names>
                    </name>
                  </person-group>
                  <article-title>Histological and scanning electron microscopy analyses of bone/implant interface using the novel Bonelike® synthetic bone graft</article-title>
                  <source>J Orthop Res</source>
                  <year>2006</year>
                  <volume>24</volume>
                  <fpage>953</fpage>
                  <lpage>958</lpage>
                  <pub-id pub-id-type="doi">10.1002/jor.20117</pub-id>
                  <?supplied-pmid 16609968?>
                  <pub-id pub-id-type="pmid">16609968</pub-id>
                </element-citation>
              </ref>
              <ref id="CR26">
                <label>26.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lobato</surname>
                      <given-names>JV</given-names>
                    </name>
                    <name>
                      <surname>Sooraj Hussain</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Botelho</surname>
                      <given-names>CM</given-names>
                    </name>
                    <name>
                      <surname>Maurício</surname>
                      <given-names>AC</given-names>
                    </name>
                    <name>
                      <surname>Lobato</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Lopes</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Afonso</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Ali</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Santos</surname>
                      <given-names>JD</given-names>
                    </name>
                  </person-group>
                  <article-title>Titanium dental implants coated with Bonelike®: clinical case report</article-title>
                  <source>Thin Solid Films</source>
                  <year>2006</year>
                  <volume>515</volume>
                  <fpage>279</fpage>
                  <lpage>284</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.tsf.2005.12.151</pub-id>
                </element-citation>
              </ref>
              <ref id="CR27">
                <label>27.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lobato</surname>
                      <given-names>JV</given-names>
                    </name>
                    <name>
                      <surname>Hussain</surname>
                      <given-names>NS</given-names>
                    </name>
                    <name>
                      <surname>Lopes</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Lobato</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Mauricio</surname>
                      <given-names>AC</given-names>
                    </name>
                    <name>
                      <surname>Afonso</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Ali</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Santos</surname>
                      <given-names>JD</given-names>
                    </name>
                  </person-group>
                  <article-title>Clinical applications of titanium dental implants coated with glass-reinforced hydroxyapatite composite (Bonelike®)</article-title>
                  <source>Int J Nanomanuf</source>
                  <year>2008</year>
                  <volume>2</volume>
                  <fpage>135</fpage>
                  <lpage>148</lpage>
                  <pub-id pub-id-type="doi">10.1504/IJNM.2008.017845</pub-id>
                </element-citation>
              </ref>
              <ref id="CR28">
                <label>28.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gutierres</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Dias</surname>
                      <given-names>AG</given-names>
                    </name>
                    <name>
                      <surname>Lopes</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Hussain</surname>
                      <given-names>NS</given-names>
                    </name>
                    <name>
                      <surname>Cabral</surname>
                      <given-names>AT</given-names>
                    </name>
                    <name>
                      <surname>Almeida</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Santos</surname>
                      <given-names>JD</given-names>
                    </name>
                  </person-group>
                  <article-title>Opening wedge high tibial osteotomy using 3D biomodelling Bonelike® macroporous structures: case report</article-title>
                  <source>J Mater Sci Mater Med</source>
                  <year>2007</year>
                  <volume>18</volume>
                  <fpage>2377</fpage>
                  <lpage>2382</lpage>
                  <pub-id pub-id-type="doi">10.1007/s10856-007-3171-x</pub-id>
                  <?supplied-pmid 17569003?>
                  <pub-id pub-id-type="pmid">17569003</pub-id>
                </element-citation>
              </ref>
              <ref id="CR29">
                <label>29.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Gutierres</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Lopes</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Sooraj Hussain</surname>
                      <given-names>N</given-names>
                    </name>
                    <name>
                      <surname>Lemos</surname>
                      <given-names>AF</given-names>
                    </name>
                    <name>
                      <surname>Ferreira</surname>
                      <given-names>JMF</given-names>
                    </name>
                    <name>
                      <surname>Afonso</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Cabral</surname>
                      <given-names>AT</given-names>
                    </name>
                    <name>
                      <surname>Almeida</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Santos</surname>
                      <given-names>JD</given-names>
                    </name>
                  </person-group>
                  <article-title>Bone ingrowth in macroporous Bonelike® for orthopaedic applications</article-title>
                  <source>Acta Biomater</source>
                  <year>2008</year>
                  <volume>4</volume>
                  <fpage>370</fpage>
                  <lpage>377</lpage>
                  <pub-id pub-id-type="doi">10.1016/j.actbio.2007.06.009</pub-id>
                  <?supplied-pmid 17716960?>
                  <pub-id pub-id-type="pmid">17716960</pub-id>
                </element-citation>
              </ref>
              <ref id="CR30">
                <label>30.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sousa</surname>
                      <given-names>RC</given-names>
                    </name>
                    <name>
                      <surname>Lobato</surname>
                      <given-names>JV</given-names>
                    </name>
                    <name>
                      <surname>Maurício</surname>
                      <given-names>AC</given-names>
                    </name>
                    <name>
                      <surname>Hussain</surname>
                      <given-names>NS</given-names>
                    </name>
                    <name>
                      <surname>Botelho</surname>
                      <given-names>CM</given-names>
                    </name>
                    <name>
                      <surname>Lopes</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Santos</surname>
                      <given-names>JD</given-names>
                    </name>
                  </person-group>
                  <article-title>A clinical report of bone regeneration in maxillofacial surgery using bonelike® synthetic bone graft</article-title>
                  <source>J Biomater Appl</source>
                  <year>2008</year>
                  <volume>22</volume>
                  <fpage>373</fpage>
                  <lpage>385</lpage>
                  <pub-id pub-id-type="doi">10.1177/0885328207078260</pub-id>
                  <?supplied-pmid 17494960?>
                  <pub-id pub-id-type="pmid">17494960</pub-id>
                </element-citation>
              </ref>
              <ref id="CR31">
                <label>31.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Campos</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Sousa</surname>
                      <given-names>AC</given-names>
                    </name>
                    <name>
                      <surname>Pinto</surname>
                      <given-names>PO</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Application of Bonelike® as synthetic bone graft in orthopaedic and oral surgery in veterinary clinical cases</article-title>
                  <source>Biomater Res</source>
                  <year>2018</year>
                  <volume>22</volume>
                  <fpage>38</fpage>
                  <pub-id pub-id-type="doi">10.1186/s40824-018-0150-x</pub-id>
                  <?supplied-pmid 30619619?>
                  <pub-id pub-id-type="pmid">30619619</pub-id>
                </element-citation>
              </ref>
              <ref id="CR32">
                <label>32.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pereira</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Simões</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Evtyugin</surname>
                      <given-names>DV</given-names>
                    </name>
                    <name>
                      <surname>Rouif</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Coimbra</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Domingues</surname>
                      <given-names>MRM</given-names>
                    </name>
                    <name>
                      <surname>Gama</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Effects of gamma irradiation and periodate oxidation on the structure of dextrin assessed by mass spectrometry</article-title>
                  <source>Eur Polym J</source>
                  <year>2018</year>
                  <volume>103</volume>
                  <fpage>158</fpage>
                  <lpage>169</lpage>
                  <pub-id pub-id-type="doi">10.1016/J.EURPOLYMJ.2018.04.011</pub-id>
                </element-citation>
              </ref>
              <ref id="CR33">
                <label>33.</label>
                <mixed-citation publication-type="other">ISO 11137–1 (2006) Sterilization of health care products — radiation — part 1: requirements for development, validation and routine control of a sterilization process for medical devices. <ext-link ext-link-type="uri" xlink:href="https://www.iso.org/standard/33952.html">https://www.iso.org/standard/33952.html</ext-link></mixed-citation>
              </ref>
              <ref id="CR34">
                <label>34.</label>
                <mixed-citation publication-type="other">ISO 11737–2 (2009) Sterilization of medical devices — microbiological methods — part 2: tests of sterility performed in the definition, validation and maintenance of a sterilization process. <ext-link ext-link-type="uri" xlink:href="https://www.iso.org/standard/44955.html">https://www.iso.org/standard/44955.html</ext-link></mixed-citation>
              </ref>
              <ref id="CR35">
                <label>35.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cortez</surname>
                      <given-names>PP</given-names>
                    </name>
                    <name>
                      <surname>Atayde</surname>
                      <given-names>LM</given-names>
                    </name>
                    <name>
                      <surname>Silva</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Armada-Da-Silva</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Fernandes</surname>
                      <given-names>MH</given-names>
                    </name>
                    <name>
                      <surname>Afonso</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Lopes</surname>
                      <given-names>MA</given-names>
                    </name>
                    <name>
                      <surname>Maurício</surname>
                      <given-names>AC</given-names>
                    </name>
                    <name>
                      <surname>Santos</surname>
                      <given-names>JD</given-names>
                    </name>
                  </person-group>
                  <article-title>Characterization and preliminary in vivo evaluation of a novel modified hydroxyapatite produced by extrusion and spheronization techniques</article-title>
                  <source>J Biomed Mater Res B Appl Biomater</source>
                  <year>2011</year>
                  <volume>99</volume>
                  <fpage>170</fpage>
                  <lpage>179</lpage>
                  <pub-id pub-id-type="doi">10.1002/JBM.B.31884</pub-id>
                  <?supplied-pmid 21714082?>
                  <pub-id pub-id-type="pmid">21714082</pub-id>
                </element-citation>
              </ref>
              <ref id="CR36">
                <label>36.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lakens</surname>
                      <given-names>D</given-names>
                    </name>
                  </person-group>
                  <article-title>Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs</article-title>
                  <source>Front Psychol</source>
                  <year>2013</year>
                  <volume>4</volume>
                  <fpage>863</fpage>
                  <pub-id pub-id-type="doi">10.3389/FPSYG.2013.00863/ABSTRACT</pub-id>
                  <?supplied-pmid 24324449?>
                  <pub-id pub-id-type="pmid">24324449</pub-id>
                </element-citation>
              </ref>
              <ref id="CR37">
                <label>37.</label>
                <mixed-citation publication-type="other">Misch CE (2015) Bone density: a key determinant for treatment planning. In: Misch CE (ed) Dent. Implant Prosthetics, 2nd ed. Mosby, pp 237–252. 10.1016/B978-0-323-07845-0.00011-7</mixed-citation>
              </ref>
              <ref id="CR38">
                <label>38</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kravitz</surname>
                      <given-names>ND</given-names>
                    </name>
                    <name>
                      <surname>Kusnoto</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Tsay</surname>
                      <given-names>TP</given-names>
                    </name>
                    <name>
                      <surname>Hohlt</surname>
                      <given-names>WF</given-names>
                    </name>
                  </person-group>
                  <article-title>The use of temporary anchorage devices for molar intrusion</article-title>
                  <source>J Am Dent Assoc</source>
                  <year>2007</year>
                  <volume>138</volume>
                  <fpage>56</fpage>
                  <lpage>64</lpage>
                  <pub-id pub-id-type="doi">10.14219/JADA.ARCHIVE.2007.0021</pub-id>
                  <?supplied-pmid 17197402?>
                  <pub-id pub-id-type="pmid">17197402</pub-id>
                </element-citation>
              </ref>
              <ref id="CR39">
                <label>39.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bohner</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Resorbable biomaterials as bone graft substitutes</article-title>
                  <source>Mater Today</source>
                  <year>2010</year>
                  <volume>13</volume>
                  <fpage>24</fpage>
                  <lpage>30</lpage>
                  <pub-id pub-id-type="doi">10.1016/S1369-7021(10)70014-6</pub-id>
                </element-citation>
              </ref>
              <ref id="CR40">
                <label>40.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Daculsi</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Legeros</surname>
                      <given-names>RZ</given-names>
                    </name>
                    <name>
                      <surname>Nery</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Lynch</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Kerebel</surname>
                      <given-names>B</given-names>
                    </name>
                  </person-group>
                  <article-title>Transformation of biphasic calcium phosphate ceramicsin vivo: Ultrastructural and physicochemical characterization</article-title>
                  <source>J Biomed Mater Res</source>
                  <year>1989</year>
                  <volume>23</volume>
                  <fpage>883</fpage>
                  <lpage>894</lpage>
                  <pub-id pub-id-type="doi">10.1002/jbm.820230806</pub-id>
                  <?supplied-pmid 2777831?>
                  <pub-id pub-id-type="pmid">2777831</pub-id>
                </element-citation>
              </ref>
              <ref id="CR41">
                <label>41.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ishikawa</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Miyamoto</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Tsuchiya</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Hayashi</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Tsuru</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Ohe</surname>
                      <given-names>G</given-names>
                    </name>
                  </person-group>
                  <article-title>Physical and histological comparison of hydroxyapatite, carbonate apatite, and β-tricalcium phosphate bone substitutes</article-title>
                  <source>Materials (Basel)</source>
                  <year>2018</year>
                  <pub-id pub-id-type="doi">10.3390/MA11101993</pub-id>
                  <?supplied-pmid 30332751?>
                  <pub-id pub-id-type="pmid">30332751</pub-id>
                </element-citation>
              </ref>
              <ref id="CR42">
                <label>42.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Atayde</surname>
                      <given-names>LM</given-names>
                    </name>
                    <name>
                      <surname>Cortez</surname>
                      <given-names>PP</given-names>
                    </name>
                    <name>
                      <surname>Afonso</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Santos</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Maurício</surname>
                      <given-names>AC</given-names>
                    </name>
                    <name>
                      <surname>Santos</surname>
                      <given-names>JD</given-names>
                    </name>
                  </person-group>
                  <article-title>Morphology effect of bioglass-reinforced hydroxyapatite (Bonelike ® ) on osteoregeneration</article-title>
                  <source>J Biomed Mater Res Part B Appl Biomater</source>
                  <year>2015</year>
                  <volume>103</volume>
                  <fpage>292</fpage>
                  <lpage>304</lpage>
                  <pub-id pub-id-type="doi">10.1002/jbm.b.33195</pub-id>
                </element-citation>
              </ref>
              <ref id="CR43">
                <label>43.</label>
                <mixed-citation publication-type="other">Pinto PO, Pinto PO, Atayde LM et al (2016) Therapeutic strategies for bone regeneration: the importance of biomaterials testing in adequate animal models. In: Tiwari A, Alenezi MR, Jun SC (eds) Adv Compos Mater, 1st ed. Wiley, pp 275–319. 10.1002/9781119242666.CH6</mixed-citation>
              </ref>
              <ref id="CR44">
                <label>44.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Sheikh</surname>
                      <given-names>Z</given-names>
                    </name>
                    <name>
                      <surname>Abdallah</surname>
                      <given-names>M-N</given-names>
                    </name>
                    <name>
                      <surname>Hanafi</surname>
                      <given-names>AA</given-names>
                    </name>
                    <name>
                      <surname>Misbahuddin</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Rashid</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Glogauer</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Mechanisms of in vivo degradation and resorption of calcium phosphate based biomaterials</article-title>
                  <source>Materials (Basel)</source>
                  <year>2015</year>
                  <volume>8</volume>
                  <fpage>7913</fpage>
                  <pub-id pub-id-type="doi">10.3390/MA8115430</pub-id>
                  <?supplied-pmid 28793687?>
                  <pub-id pub-id-type="pmid">28793687</pub-id>
                </element-citation>
              </ref>
              <ref id="CR45">
                <label>45.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Heymann</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Pradal</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Benahmed</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Cellular mechanisms of calcium phosphate ceramic degradation</article-title>
                  <source>Histol Histopathol</source>
                  <year>1999</year>
                  <volume>14</volume>
                  <fpage>871</fpage>
                  <lpage>877</lpage>
                  <pub-id pub-id-type="doi">10.14670/HH-14.871</pub-id>
                  <?supplied-pmid 10425557?>
                  <pub-id pub-id-type="pmid">10425557</pub-id>
                </element-citation>
              </ref>
              <ref id="CR46">
                <label>46.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Hreczuk-Hirst</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Chicco</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>German</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Duncan</surname>
                      <given-names>R</given-names>
                    </name>
                  </person-group>
                  <article-title>Dextrins as potential carriers for drug targeting: tailored rates of dextrin degradation by introduction of pendant groups</article-title>
                  <source>Int J Pharm</source>
                  <year>2001</year>
                  <volume>230</volume>
                  <fpage>57</fpage>
                  <lpage>66</lpage>
                  <pub-id pub-id-type="doi">10.1016/S0378-5173(01)00859-6</pub-id>
                  <?supplied-pmid 11672956?>
                  <pub-id pub-id-type="pmid">11672956</pub-id>
                </element-citation>
              </ref>
              <ref id="CR47">
                <label>47.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kaneo</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Uemura</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Tanaka</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Kanoh</surname>
                      <given-names>S</given-names>
                    </name>
                  </person-group>
                  <article-title>Polysaccharides as drug carriers: biodisposition of fluorescein-labeled dextrans in mice</article-title>
                  <source>Biol Pharm Bull</source>
                  <year>1997</year>
                  <volume>20</volume>
                  <fpage>181</fpage>
                  <lpage>187</lpage>
                  <pub-id pub-id-type="doi">10.1248/BPB.20.181</pub-id>
                  <?supplied-pmid 9057983?>
                  <pub-id pub-id-type="pmid">9057983</pub-id>
                </element-citation>
              </ref>
              <ref id="CR48">
                <label>48.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wei</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Ma</surname>
                      <given-names>JX</given-names>
                    </name>
                    <name>
                      <surname>Xu</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Gu</surname>
                      <given-names>XS</given-names>
                    </name>
                    <name>
                      <surname>Ma</surname>
                      <given-names>XL</given-names>
                    </name>
                  </person-group>
                  <article-title>Biodegradable materials for bone defect repair</article-title>
                  <source>Mil Med Res</source>
                  <year>2020</year>
                  <volume>7</volume>
                  <fpage>54</fpage>
                  <pub-id pub-id-type="doi">10.1186/S40779-020-00280-6</pub-id>
                  <?supplied-pmid 33172503?>
                  <pub-id pub-id-type="pmid">33172503</pub-id>
                </element-citation>
              </ref>
              <ref id="CR49">
                <label>49.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zhao</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Yang</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Cooper</surname>
                      <given-names>PR</given-names>
                    </name>
                    <name>
                      <surname>Khurshid</surname>
                      <given-names>Z</given-names>
                    </name>
                    <name>
                      <surname>Shavandi</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Ratnayake</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>Bone grafts and substitutes in dentistry: a review of current trends and developments</article-title>
                  <source>Molecules</source>
                  <year>2021</year>
                  <volume>26</volume>
                  <fpage>3007</fpage>
                  <pub-id pub-id-type="doi">10.3390/MOLECULES26103007</pub-id>
                  <?supplied-pmid 34070157?>
                  <pub-id pub-id-type="pmid">34070157</pub-id>
                </element-citation>
              </ref>
              <ref id="CR50">
                <label>50.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Tan</surname>
                      <given-names>WL</given-names>
                    </name>
                    <name>
                      <surname>Wong</surname>
                      <given-names>TLT</given-names>
                    </name>
                    <name>
                      <surname>Wong</surname>
                      <given-names>MCM</given-names>
                    </name>
                    <name>
                      <surname>Lang</surname>
                      <given-names>NP</given-names>
                    </name>
                  </person-group>
                  <article-title>A systematic review of post-extractional alveolar hard and soft tissue dimensional changes in humans</article-title>
                  <source>Clin Oral Implants Res</source>
                  <year>2012</year>
                  <volume>23</volume>
                  <fpage>1</fpage>
                  <lpage>21</lpage>
                  <pub-id pub-id-type="doi">10.1111/J.1600-0501.2011.02375.X</pub-id>
                  <?supplied-pmid 22211303?>
                  <pub-id pub-id-type="pmid">22211303</pub-id>
                </element-citation>
              </ref>
              <ref id="CR51">
                <label>51.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ivanova</surname>
                      <given-names>V</given-names>
                    </name>
                    <name>
                      <surname>Chenchev</surname>
                      <given-names>I</given-names>
                    </name>
                    <name>
                      <surname>Zlatev</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Mijiritsky</surname>
                      <given-names>E</given-names>
                    </name>
                  </person-group>
                  <article-title>Correlation between primary, secondary stability, bone density, percentage of vital bone formation and implant size</article-title>
                  <source>Int J Environ Res Public Health</source>
                  <year>2021</year>
                  <volume>18</volume>
                  <fpage>6994</fpage>
                  <pub-id pub-id-type="doi">10.3390/IJERPH18136994</pub-id>
                  <?supplied-pmid 34208849?>
                  <pub-id pub-id-type="pmid">34208849</pub-id>
                </element-citation>
              </ref>
              <ref id="CR52">
                <label>52.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Goiato</surname>
                      <given-names>MC</given-names>
                    </name>
                    <name>
                      <surname>Dos Santos</surname>
                      <given-names>DM</given-names>
                    </name>
                    <name>
                      <surname>Santiago</surname>
                      <given-names>JF</given-names>
                    </name>
                    <name>
                      <surname>Moreno</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Pellizzer</surname>
                      <given-names>EP</given-names>
                    </name>
                  </person-group>
                  <article-title>Longevity of dental implants in type IV bone: a systematic review</article-title>
                  <source>Int J Oral Maxillofac Surg</source>
                  <year>2014</year>
                  <volume>43</volume>
                  <fpage>1108</fpage>
                  <lpage>1116</lpage>
                  <pub-id pub-id-type="doi">10.1016/J.IJOM.2014.02.016</pub-id>
                  <?supplied-pmid 24679842?>
                  <pub-id pub-id-type="pmid">24679842</pub-id>
                </element-citation>
              </ref>
              <ref id="CR53">
                <label>53.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Mohajerani</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Roozbayani</surname>
                      <given-names>R</given-names>
                    </name>
                    <name>
                      <surname>Taherian</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Tabrizi</surname>
                      <given-names>R</given-names>
                    </name>
                  </person-group>
                  <article-title>The risk factors in early failure of dental implants: a retrospective study</article-title>
                  <source>J Dent (Shiraz, Iran)</source>
                  <year>2017</year>
                  <volume>18</volume>
                  <fpage>298</fpage>
                  <lpage>303</lpage>
                </element-citation>
              </ref>
              <ref id="CR54">
                <label>54.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Huang</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Wu</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Hunziker</surname>
                      <given-names>E</given-names>
                    </name>
                  </person-group>
                  <article-title>The clinical significance of implant stability quotient (ISQ) measurements: a literature review</article-title>
                  <source>J Oral Biol Craniofacial Res</source>
                  <year>2020</year>
                  <volume>10</volume>
                  <fpage>629</fpage>
                  <pub-id pub-id-type="doi">10.1016/J.JOBCR.2020.07.004</pub-id>
                </element-citation>
              </ref>
              <ref id="CR55">
                <label>55.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fernández</surname>
                      <given-names>MPR</given-names>
                    </name>
                    <name>
                      <surname>Gehrke</surname>
                      <given-names>SA</given-names>
                    </name>
                    <name>
                      <surname>Mazón</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>Calvo-Guirado</surname>
                      <given-names>JL</given-names>
                    </name>
                    <name>
                      <surname>De Aza</surname>
                      <given-names>PN</given-names>
                    </name>
                  </person-group>
                  <article-title>Implant stability of biological hydroxyapatites used in dentistry</article-title>
                  <source>Mater (Basel, Switzerland)</source>
                  <year>2017</year>
                  <volume>10</volume>
                  <fpage>644</fpage>
                  <pub-id pub-id-type="doi">10.3390/MA10060644</pub-id>
                </element-citation>
              </ref>
              <ref id="CR56">
                <label>56</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chen</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Lyons</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Tawse-Smith</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Ma</surname>
                      <given-names>S</given-names>
                    </name>
                  </person-group>
                  <article-title>Clinical significance of the use of resonance frequency analysis in assessing implant stability: a systematic review</article-title>
                  <source>Int J Prosthodont</source>
                  <year>2019</year>
                  <volume>32</volume>
                  <fpage>51</fpage>
                  <lpage>58</lpage>
                  <pub-id pub-id-type="doi">10.11607/IJP.6048</pub-id>
                  <?supplied-pmid 30677112?>
                  <pub-id pub-id-type="pmid">30677112</pub-id>
                </element-citation>
              </ref>
              <ref id="CR57">
                <label>57.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Rodrigo</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Aracil</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Martin</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Sanz</surname>
                      <given-names>M</given-names>
                    </name>
                  </person-group>
                  <article-title>Diagnosis of implant stability and its impact on implant survival: a prospective case series study</article-title>
                  <source>Clin Oral Implants Res</source>
                  <year>2010</year>
                  <volume>21</volume>
                  <fpage>255</fpage>
                  <lpage>261</lpage>
                  <pub-id pub-id-type="doi">10.1111/J.1600-0501.2009.01820.X</pub-id>
                  <?supplied-pmid 19958375?>
                  <pub-id pub-id-type="pmid">19958375</pub-id>
                </element-citation>
              </ref>
              <ref id="CR58">
                <label>58.</label>
                <mixed-citation publication-type="other">Monje A, Ravidà A, Wang H-L, Helms J, Brunski J (2019) Relationship between primary/mechanical and secondary/biological implant stability. Int J Oral Maxillofac Implants 34:s7–s23. 10.11607/JOMI.19SUPPL.G1</mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
